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Carmona: Dude, Where's My Patent?: Illegality, Morality, and the Patentabi

DUDE, WHERE’S MY PATENT?: ILLEGALITY,
MORALITY, AND THE PATENTABILITY OF
MARIJUANA
“[A] country without a patent office and good patent laws [is]
just a crab, and [cannot] travel any way but sideways or
backways.”–Mark Twain
I. INTRODUCTION
Ben Holmes is a “cannabis seed geek.” 1 After leaving a securities
analyst position at Merrill Lynch, Holmes became a self-taught scientist,
engineer, and botanist dedicated to developing high-quality cannabis
seeds.2 Holmes’ most prized invention is the Otto II, a medical-grade
marijuana strain.3 In January 2015, Holmes filed a plant patent application
to protect his Otto II strain and, if awarded, Holmes’s patent covering the
Otto II would be the first plant patent issued protecting a cannabis strain. 4
As the marijuana industry continues to grow rapidly, marijuana
entrepreneurs are concerned large companies seeking to capitalize on
marijuana will enter the industry, steal their intellectual property, and
take away their market.5 Accordingly, as states legalize marijuana for
Jason Blevins, Pot Growers Cultivating in the Shadows Seek U.S. Patent Protection, DENVER
POST (Dec. 19, 2014), http://www.denverpost.com/2014/12/19/pot-growers-cultivatingin-the-shadows-seek-u-s-patent-protection/ [https://perma.cc/HB37-DFNG].
Most
recently, the United States Patent and Trademark Office (“USPTO”) issued the “first-ever
patent for a plant containing significant amounts of THC[.]” Greg Walters, What a Looming
Patent War Could Mean for the Future of the Marijuana Industry, VICE NEWS (Apr. 20, 2016),
https://news.vice.com/article/a-patent-for-cannabis-plants-is-already-a-reality-and-moreare-expected-to-follow [https://perma.cc/C6HK-MRBP].
Cannabidiol (“CBD”) is
marijuana’s major non-psychoactive ingredient, while tetrahydrocannabinol (“THC”) is the
plant’s psychoactive compound. Id. CBD has been credited with having antipsychotic
effects. Id. U.S. Pat. No. 9,095,554 (“’554 Patent”), which was issued August 4, 2015, “relates
to specialty cannabis plants, compositions and methods for making and using said cannabis
plants and compositions derived thereof.” U.S. Pat. No. 9,095,554 (Mar. 17, 2014). The ’554
Patent is a utility patent, whereas the patent Ben Holmes seeks is a plant patent. Id.
2
See Blevins, supra note 1 (telling the story of Ben Holmes, a “self-taught scientist,
engineer, farmer[,] and cannabis seed geek” who is applying to obtain the first patent
protecting a marijuana strain).
3
See id. (indicating Holmes’s Otto II is a “high-CBD, low-THC strain” that could “fuel
medical therapies”).
4
Id.
5
See Matt Ferner, Legal Marijuana Is the Fastest-Growing Industry in the U.S.: Report,
HUFFINGTON POST (Jan. 26, 2015), http://www.huffingtonpost.com/2015/01/26/
marijuana-industry-fastest-growing_n_6540166.html
[https://perma.cc/S99X-EQ7Z]
(“[L]egal marijuana is the fastest-growing industry in the [United States] . . . .”). In fact, the
marijuana industry was a $2.7 billion market in 2014, growing 74 percent from 2013. Id. If
the trend towards legalization continues, it could become more lucrative than the National
Football League (“NFL”) industry by 2020. Christopher Ingraham, The Marijuana Industry
1

651

Produced by The Berkeley Electronic Press, 2017

Valparaiso University Law Review, Vol. 51, No. 3 [2017], Art. 5

652

VALPARAISO UNIVERSITY LAW REVIEW

[Vol. 51

medical or recreational use, marijuana entrepreneurs become increasingly
interested in seeking intellectual property protection. 6 Specifically,
entrepreneurs are interested in patent protection.7 However, marijuana
remains illegal under federal law, and because patent law is established
under federal law, attorneys do not know whether the United States
Could Be Bigger Than the NFL by 2020, WASH. POST (Oct. 24, 2014),
http://www.washingtonpost.com/news/wonkblog/wp/2014/10/24/the-marijuanaindustry-could-be-bigger-than-the-nfl-by-2020/ [https://perma.cc/VZ48-23BE]. See also
Lisa Shuchman, Roll Another Pot Patent (For the Road), CORP. COUNSEL (Apr. 1, 2015),
http://www.corpcounsel.com/id=1202722064373/Roll-Another-Pot-Patent-40For-theRoad41 [https://perma.cc/9YVW-Z2Q6] (explaining marijuana entrepreneurs, such as
Holmes, believe patenting their marijuana strain is important to prevent intellectual property
theft and facilitate licensing); Blevins, supra note 1 (quoting Chad Ruby, the Chief Operating
Officer (“COO”) of United Cannabis Corp., a publicly-traded corporation based in Denver,
Colorado that has filed for draft patents on ratios of cannabinoids: “We don’t want to waste
a bunch of time and a bunch of money and a bunch of effort only to have someone take all
our work . . . .”). Holmes, who has experience in the financial sector, explained if intellectual
property protection is available, large companies, once a “big cannabis industry develops,”
will not be able to abuse the small breeders and producers and instead will “buy up the little
ones.” Shuchman, supra note 5. Large pharmaceutical companies have already shown an
interest in the marijuana industry’s potential. Id. For example, GW Pharma Ltd., a U.K.based pharmaceutical company, is “one of the most active seekers of patents for cannabis
plants, extracts or formulations . . . .” Id. Tobacco companies are also expected to become
interested in the marijuana industry because they “already have the infrastructure needed
to grow marijuana plants” on a large scale. Id. Furthermore, according to industry watchers,
companies like Monsanto, Altria Group, Pfizer, Walgreens, and Anheuser-Busch Indiana
Beverage are expected to become interested in the marijuana market’s potential. Blevins,
supra note 1.
6
See State Medical Marijuana Laws, NAT’L CONF. OF ST. LEGIS. (Oct. 16, 2015),
http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx
[https://perma.cc/EL7R-T5FS] (discussing state medical marijuana laws and noting twentythree states, the District of Columbia, and Guam have laws permitting medical marijuana
programs); see also Chris Boyette & Jacque Wilson, It’s 2015: Is Weed Legal in Your State?,
CNN (Jan. 7, 2015), http://www.cnn.com/2015/01/07/us/recreational-marijuana-laws/
[https://perma.cc/GXB8-FVXN] (stating four states—Washington, Colorado, Alaska, and
Oregon—and Washington D.C. have legalized recreational use of marijuana); Blevins, supra
note 1 (quoting Ben Holmes: “[W]ith companies forming and making larger investments,
the desire to protect intellectual property is becoming paramount. Bleeding-edge stuff, right
here.”); Shuchman, supra note 5 (describing the marijuana industry’s desire to obtain
intellectual property protection and noting it is unclear whether the USPTO will issue
patents on pending marijuana-related applications, such as the one filed by Ben Holmes).
7
See supra note 5 and accompanying text (highlighting the reasons marijuana
entrepreneurs are interested in patent protection, including entrepreneurs’ concerns that
they will not able to protect their small businesses from large companies entering the
marijuana industry and stealing market share unless they have patent protection); see also
Amanda Ciccatelli, Patent Protection for Marijuana Plants Is the “Holy Grail” of the Marijuana
Industry, INSIDE COUNS. (June 17, 2016), http://www.insidecounsel.com/2016/06/17/
patent-protection-for-marijuana-plants-is-the-holy [https://perma.cc/SEB7-WL2A] (noting
that obtaining a patent protecting a marijuana strain is the “holy grail” of the marijuana
industry).
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Patent and Trademark Office (“USPTO”) will issue patents protecting
strains of cannabis.8 Hence, it is unclear whether Holmes will be able to
obtain a plant patent protecting his Otto II strain.9
This Note considers what role, if any, illegality should play in a
determination of patentable utility by examining the patentable utility of
marijuana strains and marijuana-related inventions.10 The Note proposes
illegality should not affect the patentable utility of an invention because
such a rejection would be inconsistent with the goals of the patent
system.11 Therefore, marijuana-related inventions qualify for patent
protection despite marijuana’s illegal status under federal law.12 First,
Part II discusses federal and state legislation on marijuana and provides
an overview of patent law.13 Second, Part III analyzes how marijuana’s

See 21 U.S.C. § 812 (2012) (classifying marijuana as a Schedule I substance). The
manufacturing, distribution, dispensing, or possession of Schedule I substances is unlawful
and subject to criminal penalties. § 841. See also Ryan Davis, Marijuana Patent Applications
Face Tough Road at USPTO, LAW360 (Jan. 8, 2015), http://www.law360.com/articles/
609140/marijuana-patent-applications-face-tough-road-at-uspto [https://perma.cc/3MTM
-ZHH3] (pointing out many attorneys believe the USPTO will not issue patents protecting a
substance that is illegal under federal law). The lawyers quoted by Law360 as expressing
concerns regarding the patentability of marijuana strains include: David Resnick of Nixon
Peabody LLP, John Dragseth of Fish & Richardson PC, and Douglas Sorocco of Dunlap
Codding. Id. However, other attorneys have indicated that “simply because something is
illegal doesn’t make it ineligible for a patent and that patents on marijuana strains may be
permissible.” Id. Among the lawyers quoted by Law360 as being optimistic that the USPTO
will grant patents protecting marijuana strains are: Robert Traver of Sheridan Ross PC, Erich
Veitenheimer of Cooley LLP, and Jeremy Hanika and Anthony Marshall of Hanika &
Marshall LLP. Id. See also Blevins, supra note 1 (quoting Chad Ruby, the COO of United
Cannabis: “Everyone in this industry is sitting and waiting on the federal level to see what
they will allow.”); Shuchman, supra note 5 (quoting Douglas Berman, a professor at Ohio
State University’s Moritz College of Law: “No one is really sure of the law yet . . . .”);
Amanda Ciccatelli, Planting the Seed for IP Protection of Marijuana Brands, INSIDE COUNS. (Feb.
24,
2016),
http://www.insidecounsel.com/2016/02/24/planting-the-seeds-for-ipprotection-of-marijuana [https://perma.cc/8ZFD-WY8Q] (“The dichotomy of legalization
at the state level and the illegality of marijuana at the federal level have created a circular
argument: IP laws and protection are within the domain of federal law; federal law insists
that the production, sale, and the use of marijuana are illegal and, therefore, the grant of
federal IP protection is limited.”).
9
See supra note 8 and accompanying text (illustrating the uncertainties surrounding the
patentability of marijuana-related inventions).
10
See infra Part III.C (analyzing the patentability of marijuana-related inventions and
marijuana strains).
11
See infra Part III.D.2 (explaining why it would be inconsistent with the goals of the
patent system to promote innovation and disclosure if illegality were considered in
determining an invention’s patentable utility).
12
See infra Part IV (concluding marijuana-related inventions should not lack patentable
utility merely because of marijuana’s classification as an illegal substance under federal law).
13
See infra Part II (discussing the Controlled Substances Act, state legislation legalizing
marijuana, and the Patent Act).
8
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illegality under federal law affects the patentable utility of marijuana
strains and marijuana-related inventions and recommends illegality
should not be considered when determining patentable utility. 14 Last, Part
IV concludes marijuana strains and marijuana-related inventions would
not lack patentable utility. 15
II. BACKGROUND
Patent protection is “the strongest form of intellectual property
protection.”16 For that reason, as states legalize recreational and medical
marijuana, marijuana entrepreneurs become increasingly interested in
protecting their inventions under patent law. 17 However, patent law is a
matter of federal law, and marijuana remains an illegal substance under
federal law.18 As a result, it is unclear whether the USPTO, a federal
administrative agency, will issue patents protecting marijuana strains and
marijuana-related inventions.19 Part II provides a background to
marijuana laws and the patent process.20 First, Part II.A distinguishes
federal and state marijuana legislation. 21 Next, Part II.B explores pertinent
patent law principles.22
Finally, Part II.C introduces the issues
surrounding the patentability of marijuana based on its classification as
an illegal substance under federal law.23

14
See infra Part III (examining what role, if any, illegality should play in a determination
of patentable utility).
15
See infra Part IV (concluding marijuana-related patent applications do not lack utility
simply based on marijuana’s federal classification as an illegal substance).
16
Sam Kamin & Viva Moffat, Trademark Laundering, Useless Patents, and Other IP Challenges
for the Marijuana Industry, 73 WASH. & LEE 217, 264 (2016).
17
See supra notes 5–6 and accompanying text (outlining the reasons marijuana
entrepreneurs are interested in obtaining patent protection).
18
See supra note 8 and accompanying text (identifying the federal ban on marijuana and
the establishment of federal patent law).
19
See supra note 8 and accompanying text (discussing attorney concerns on the
patentability of marijuana strains and marijuana-related inventions). While some attorneys
argue the USPTO will most likely deny patent applications on a substance deemed illegal by
federal law, there is, however, no basis to determine how the USPTO will respond to
marijuana plant patent applications because “there has never been a precisely analogous
situation where a substance is legal in some states, but still technically illegal nationwide.”
Davis, supra note 8.
20
See infra Part II (discussing federal and state legislation criminalizing and legalizing,
respectively, the use of marijuana in the United States, as well as basis patent law principles).
21
See infra Part II.A (exploring federal and state marijuana legislation).
22
See infra Part II.B (providing a brief overview of relevant patent law principles).
23
See infra Part II.C (presenting the patentability issues surrounding marijuana strains and
marijuana-related inventions).
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A. Marijuana Laws in the United States
Cannabis, more commonly known as marijuana or weed, was
accessible and freely used by Americans before it first became federally
regulated in the early twentieth century with the passage of the Pure Food
and Drug Act.24 State regulation followed, and by 1931, twenty-two states
had enacted laws outlawing or regulating marijuana. 25 Nonetheless,
marijuana remained legal under federal law until 1970, when Congress
passed the Comprehensive Drug Abuse Prevention and Control Act
(“CDAPCA”).26 Specifically, Title II of the CDAPCA, the Controlled
Substances Act (“CSA”), is the “key federal drug policy” regulating
controlled substances, including marijuana.27
The CSA was passed by Congress and signed into law by President
Nixon to decrease drug abuse and regulate the traffic of controlled
substances.28 Under the CSA, drugs, substances, and chemicals used to
24
See generally Helia Garrido Hull, Lost in the Weeds of Pot Law: The Role of Legal Ethics in
the Movement to Legalize Marijuana, 119 PENN ST. L. REV. 333, 336–38 (2014) (exploring the
history of marijuana use in America); see also Stephen Siff, The Illegalization of Marijuana: A
Brief History, ORIGINS (May 2014), http://origins.osu.edu/article/illegalization-marijuanabrief-history/page/0/0 [https://perma.cc/B7YY-CGEY] (providing a brief history of
marijuana laws in the United States). The Pure Food and Drug Act was passed in 1906 and
required medicine companies to indicate on medicine labels whether the remedy contained
cannabis. Siff, supra note 24. Then, Congress enacted the Marijuana Tax Act in 1937,
requiring people who dealt with marijuana commercially, prescribed it, or possessed it “to
purchase a tax stamp in order to possess marijuana legally.” Garrido Hull, supra note 24, at
337.
25
See Richard J. Bonnie & Charles H. Whitebread, The Forbidden Fruit and the Tree of
Knowledge: An Inquiry into the Legal History of American Marijuana Prohibition, 56 VA. L. REV.
971, 1010–20 (1970) (examining the development of marijuana state legislation). By 1931,
twenty-one states had restricted the sale of marijuana; “one state had prohibited its use for
any purpose, and four states had outlawed its cultivation.” Id. at 1010–11. For example, in
1914, New York prohibited marijuana, and in 1905, Utah prohibited the sale or possession of
marijuana. Id. at 1010.
26
See Dana Graham, Decriminalization of Marijuana: An Analysis of the Laws in the United
States and the Netherlands and Suggestions for Reform, 23 LOY. L.A. INT’L & COMP. L. REV. 297,
301 (2001) (stating the Comprehensive Drug Abuse Prevention and Control Act
(“CDAPCA”) “consolidated federal laws addressing drug trafficking and drug abuse,” as
well as “finalized the prohibition on drugs including marijuana . . . .”); see also Siff, supra note
24 (noting the CDAPCA classified marijuana in the most restrictive category of drugs).
27
See Garrido Hull, supra note 24, at 338 (discussing federal law controlling marijuana).
28
See Robert A. Mikos, Preemption under the Controlled Substances Act, 16 J. HEALTH CARE
L. & POL’Y 5, 10 (2013) (citing Gonzales v. Raich, 545 U.S. 1, 12 (2005)) (“Congress passed the
CSA primarily to ‘conquer drug abuse and to control the legitimate and illegitimate traffic
in controlled substances.’”); see generally Matthew B. Hodroff, The Controlled Substances Act:
Time to Reevaluate Marijuana, 36 WHITTIER L. REV. 117, 117 (2014) (exploring the Controlled
Substances Act (“CSA”) and proposing a proper reassessment of marijuana under the Act);
Robert A. Mikos, On the Limits of Supremacy: Medical Marijuana and the States’ Overlooked
Power to Legalize Federal Crime, 62 VAND. L. REV. 1421, 1427–36 (2009) (providing background

Produced by The Berkeley Electronic Press, 2017

Valparaiso University Law Review, Vol. 51, No. 3 [2017], Art. 5

656

VALPARAISO UNIVERSITY LAW REVIEW

[Vol. 51

make drugs are classified into five schedules, depending on the
substance’s potential for abuse, accepted medical use, and safety for use. 29
Congress classified marijuana as a Schedule I substance—“the most
dangerous class of drugs”—along with heroin, LSD, and ecstasy, among
others.30 The decision to classify marijuana as a Schedule I substance
reflects the finding that marijuana has a high potential for abuse, no
currently accepted medical use, and lack of accepted safety for use.31
Accordingly, manufacturing, distributing, dispensing, and possessing
marijuana is prohibited under federal law and subject to criminal
prosecution.32
Despite efforts to the contrary, Congress refuses to reschedule
marijuana, and the Drug Enforcement Agency (“DEA”) routinely rejects
requests to administratively reschedule marijuana. 33 Thus, it appears
information on the CSA and state medical marijuana laws).
29
See 21 U.S.C. § 812 (2012) (establishing the five schedules of controlled substances and
listing the findings required for each schedule). See generally Drug Scheduling, DRUG
ENFORCEMENT ADMIN. (Oct. 21, 2015), http://www.dea.gov/druginfo/ds.shtml
[https://perma.cc/36SJ-245E] (explaining drug scheduling).
30
Drug Scheduling, supra note 29. See also § 812(c) (instructing “any material, compound,
mixture, or preparation, which contains any quantity of any of the following hallucinogenic
substances . . . (10) Marihuana” is a Schedule I drug or substance).
31
See § 812(b) (indicating a substance should not be placed in Schedule I unless the
following findings are made with respect to the substance: “(A) The drug or other substance
has a high potential for abuse. (B) The drug or other substance has no currently accepted
medical use in treatment in the United States. (C) There is a lack of accepted safety for use
of the drug or other substance under medical supervision.”).
32
See § 841 (listing the acts considered unlawful and the penalties for a violation). Under
§ 841 it is unlawful “for any person knowingly or intentionally (1) to manufacture distribute,
or dispense, or possess with intent to manufacture, distribute, or dispense, a controlled
substance; or (2) to create, distribute, or dispense, or possess with intent to distribute or
dispense, a counterfeit substance.” § 841(a). The penalties for a violation vary depending
on the substance and amount of the substance. § 841(b).
33
See Mikos, supra note 28, at 1434–35 (noting Congress has rejected proposals to
reschedule marijuana and that the federal government refuses to legalize marijuana). Under
the CSA, the Attorney General has the power to reschedule drugs. § 814(a). The Attorney
General can also delegate this authority to the Drug Enforcement Agency (“DEA”). 28 C.F.R.
§ 0.100(b) (2012). See also Alliance for Cannabis Therapeutics v. Drug Enforcement Admin.,
15 F.3d 1131, 1132–33 (D.C. Cir. 1997) (denying petitions to review an order issued by the
DEA denying the rescheduling of marijuana); United States v. Pickard, 100 F. Supp. 3d 981,
988 (E.D. Cal. 2015) (denying defendant’s motion to challenge marijuana’s status as a
Schedule I substance); Elizabeth Roth, Light, Smoke, and Fire: How State Law Can Provide
Medical Marijuana Users Protection from Workplace Discrimination, 55 B.C. L. REV. 1759, 1765
n.41 (2014) (reviewing unsuccessful efforts to reschedule marijuana). In fact, the Obama
Administration opposed the legalization of marijuana. See Marijuana, OFF. OF NAT’L DRUG
CONTROL POL’Y (Oct. 21, 2015), https://www.whitehouse.gov/ondcp/marijuana
[https://perma.cc/U2NK-PWT4] (“The Administration steadfastly opposes legalization of
marijuana and other drugs because legalization would increase the availability and use of
illicit drugs, and pose significant health and safety risks to all Americans, particularly young
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marijuana will remain illegal under federal law in the near future. 34 That
is not the case, however, at the state level.35
Starting in 1996, states started passing laws legalizing marijuana for
medical or recreational use, resulting in conflicting federal and state
marijuana policies.36 California was the first state to legalize the medical
use of marijuana in 1996 when Proposition 215 was passed. 37 Since then,
people.”); see also Marijuana Resource Center: State Laws Related to Marijuana, OFF. OF NAT’L
DRUG CONTROL POL’Y (Oct. 20, 2015), https://www.whitehouse.gov/ondcp/state-lawsrelated-to-marijuana [https://perma.cc/K4W9-LQ5T] (asserting the Department of Justice
is “committed to enforcing the Controlled Substances Act (CSA)”). But see Office of the
Deputy Attorney General, Guidance Regarding Marijuana Enforcement, Memorandum for all
United States Attorneys, U.S. DEP’T OF JUST. (Aug. 29, 2013), http://www.justice.gov/iso/
opa/resources/3052013829132756857467.pdf [https://perma.cc/A6H6-DJDQ] (advising it
is not an efficient use of federal resources to focus federal drug enforcement efforts in states
that have legalized marijuana in some form as long as they have “implemented strong and
effective regulatory and enforcement systems to control the cultivation, distribution, sale,
and possession of marijuana, conduct in compliance with those laws and regulations”).
34
See State-By-State Medical Marijuana Laws, MARIJUANA POL’Y PROJECT, at 2 (2001),
http://medicalmarijuana.procon.org/sourcefiles/state-by-state-guidelines-remove-threatof-arrest.pdf [https://perma.cc/A5EP-LB2Y] (providing that despite multiple petitions and
“[a]fter years of litigation, it has essentially been determined the DEA will not move the
substance into a less restrictive schedule without an official determination of ‘safety and
efficacy’ by the U.S. Food and Drug Administration (FDA).”); see also supra note 33 and
accompanying text (describing the opposition to rescheduling marijuana); but see S.683, 114th
Cong. (2015) (proposing to reschedule marijuana as a Schedule II substance and amending
the CSA to protect individuals acting in compliance with marijuana state laws from federal
prosecution). Senator Cory Booker of New Jersey introduced this Bill in the Senate on March
10, 2015. S.683–Compassionate Access, Research Expansion, and Respect States Act of 2015,
CONGRESS.GOV (Oct. 21, 2015), https://www.congress.gov/bill/114th-congress/senatebill/683/actions [https://perma.cc/MCS3-VFEW]. The Bill was read twice and referred to
the Senate Commi6ttee on the Judiciary. Id. The Senate’s bill House counterpart is H.R. 1538,
and was introduced by Steve Cohen of Tennessee on March 23, 2015. H.R. 1538–CARERS
Act of 2015, CONGRESS.GOV (Oct. 21, 2015), https://www.congress.gov/bill/114thcongress/house-bill/1538 [https://perma.cc/2XNN-EQAR]. H.R. 1538 was last under
consideration by the House Subcommittee on Crime, Terrorism, Homeland Security, and
Investigation in April. Id. A similar House bill is H.R. 1940, introduced April 22, 2015. H.R.
1940–Respect State Marijuana Laws Act of 2015, CONGRESS.GOV (Oct. 21, 2015),
https://www.congress.gov/bill/114th-congress/house-bill/1940 [https://perma.cc/P43TA9KR].
35
See infra Part II.A.2 (summarizing recent state legislation legalizing marijuana).
36
See Marijuana Resource Center: State Laws Related to Marijuana, supra note 34 (indicating
twenty-three states and Washington D.C. have legalized the medical use of marijuana since
1996); see also State Medical Marijuana Laws, supra note 6 (asserting California was the first
state to legalize the medical use of marijuana in 1996); State-By-State Medical Marijuana Laws,
supra note 34, at 1, 3, 5 (providing an overview of state medical marijuana laws, federal court
rulings, and attempts to reschedule marijuana).
37
See State Medical Marijuana Laws, supra note 6 (asserting California became the first state
to legalize the use of medical marijuana when voters passed Proposition 215); see also
Hodroff, supra note 28, at 124–25 (indicating Arizona and California were the first states to
pass laws allowing the medical use of marijuana). Proposition 215, also known as the
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twenty-two states, Washington D.C., and Guam have passed laws
authorizing the medical use of marijuana.38 Furthermore, starting in 2012,
four states and the District of Columbia passed initiatives allowing the
sale and distribution of marijuana for recreational purposes. 39 Scholars
contend that by the end of 2016, up to another eleven states will have
legalized marijuana.40
In sum, today, twenty-three states and the District of Columbia have
legalized medical marijuana.41 In addition, as of October 2015, four states
allow the recreational use of marijuana.42 However, these laws do not
change the fact that marijuana remains illegal under federal law. 43
Because federal law governs patent law, the federal ban on marijuana may
affect the patentability of marijuana strains and marijuana-related

Compassionate Use Act of 1996, specifically addressed which medical conditions were
eligible to be treated with marijuana. Hodroff, supra note 28, at 125. On the other hand,
Arizona’s initiative, Proposition 203, concerned all Schedule I substances, allowing doctors
to prescribe Schedule I drugs to terminally ill patients under certain circumstances. Id.
38
See Marijuana Resource Center: State Laws Related to Marijuana, supra note 34 (indicating
the laws of the twenty-three states “vary greatly in their criteria and implementation” and
that regulations on the use of marijuana may also vary at the county level). As of October
21, 2015, the following states and the District of Columbia allow medical marijuana: Alaska,
Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Maine, Maryland,
Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New
Mexico, New York, Oregon, Rhode Island, Vermont, and Washington. State Medical
Marijuana Laws, supra note 6.
39
See Marijuana Resource Center: State Laws Related to Marijuana, supra note 34
(summarizing the status of marijuana use throughout the states). The four states allowing
the sale and distribution of marijuana for recreational purposes are: Alaska, Colorado,
Oregon, and Washington. Id. Colorado and Washington were the first to legalize
recreational marijuana when voters passed Amendment 64 and Initiative 502, respectively.
Hodroff, supra note 28, at 125–26. Then, in 2014, Alaska passed Ballot Measure 2, the District
of Columbia passed Initiative 71, and Oregon passed Measure 91. See State Medical Marijuana
Laws, supra note 6 (indicating which states allow for the retail sale and adult use of marijuana
and providing links to the initiatives).
40
See Christopher Ingraham, These Are the States That Could Legalize Pot Next, WASH. POST
(July 19, 2015), http://www.washingtonpost.com/news/wonkblog/wp/2015/07/
19/these-are-the-states-that-could-legalize-pot-next/
[https://perma.cc/6WYU-96CC]
(according to Ballotpedia—a website that tracks legislation—initiatives legalizing marijuana
may appear in eleven states in 2016).
41
See supra note 38 and accompanying text (listing the states that have legalized medical
marijuana).
42
See supra note 39 and accompanying text (showing the states that have legalized
recreational marijuana). The use of “today” refers to the time period in which this Note was
written.
43
See Marijuana Resource Center: State Laws Related to Marijuana, supra note 36 (discussing
state laws related to the medical and recreational use of marijuana and noting that these state
laws “do not change the fact that using marijuana continues to be an offense under Federal
law”).
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inventions developed in states where marijuana use is otherwise legal. 44
Therefore, an overview of patent law is needed. 45
B. Patent Law Overview
The primary sources of patent law in the United States are the
Constitution, federal statutes and regulations, and federal judicial
opinions interpreting and applying these statutes and regulations. 46 The
Founding Fathers recognized the importance of a patent system, granting
Congress the power “[t]o promote the Progress of Science and useful Arts,
by securing for limited Times to Authors and inventors the exclusive Right
to their respective Writings and Discoveries.” 47 The Patent Act of 1836
provided the basis for the modern patent system, and the amended Patent
Act of 1952 is the statute that governs patent law today. 48
44
See supra note 8 and accompanying text (explaining why some lawyers think the USPTO
will not issue patents protecting marijuana strains based on marijuana’s status as an illegal
substance under federal law).
45
See infra Part II.B (discussing the requirements for patentability and the different types
of patents available).
46
See JANICE M. MUELLER, PATENT LAW 31 (2009) (listing the sources of patent law). The
Patent Act of 1952, the basis of the modern patent system, was codified in Title 35 of the
United States Code. Id. at 33–34. The sections of the code that “impact the operations of the
[USPTO] are implemented through the agency’s governing regulations.” Id. at 34. These
regulations are in Title 37 of the Code of Federal Regulations. Id. Furthermore, the USPTO
publishes the Manual of Patent Examining Procedure (“MPEP”), which outlines the laws
and regulations patent examiners follow when examining patent applications. Id. However,
the MPEP is simply an operations manual for patent examiners and, therefore, does not have
“the force and effect of the law.” Id. Nonetheless, it is a useful resource for patent attorneys,
and courts are willing to give the MPEP “judicial notice” to the extent that it does not conflict
with the Patent Act. In re Fisher, 421 F.3d 1365, 1372 (Fed. Cir. 2005).
47
U.S. CONST. art. I, § 8, cl. 8. District courts have original jurisdiction over cases that
“arise under any Act of Congress relating to patents[,]” according to 28 U.S.C § 1338, and the
U.S. Court of Appeals for the Federal Circuit (“CAFC”) has exclusive jurisdiction over
appeals from final decisions of district courts relating to patents. 28 U.S.C. § 1295 (2012).
Before Congress created the CAFC in 1982, the “appropriate federal regional circuit court of
appeals for the federal district court in question” would review appeals of judgments in
patent cases. MUELLER, supra note 46, at 38. The CAFC was formed by merging the U.S.
Court of Customs and Patent Appeals and the appellate division of the U.S. Court of Claims.
U.S. Court of Appeals for the Federal Circuit, Court Jurisdiction (Oct. 23, 2015),
http://www.cafc.uscourts.gov/the-court/court-jurisdiction
[https://perma.cc/B28J63BA]. The CAFC adopted as binding precedent the decisions of both of its predecessor
courts. MUELLER, supra note 46, at 34. In addition, the en banc court of the CAFC can “change
the law or overrule existing precedent.” Id. Nonetheless, the U.S. Supreme Court can review
the CAFC’s decisions. Id.
48
See MUELLER, supra note 46, at 33 (summarizing the history and development of the
Patent System in the United States). The first patent statute passed by Congress was the
Patent Act of 1790; however, the Patent Act of 1836 provided the basis for the modern patent
system. EDWARD C. WALTERSCHEID, TO PROMOTE THE PROGRESS OF USEFUL ARTS: AMERICAN
PATENT LAWS AND ADMINISTRATION, 1798-1836 1, 3 (1998. See also PAUL GOLDSTEIN & R.
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The USPTO grants three types of patents: utility patents, design
patents, and plant patents.49 First, Part II.B.1 examines the three different
types of patents and explains the statutory requirements for patent
protection.50 Next, Part II.B.2 provides an overview of the patent
prosecution process.51
1.

Types of Patents and Requirements for Protection

The majority of the patents issued by the USPTO are utility patents.52
Utility patents protect the way an invention is used and the way it works. 53
Further, utility patents have a term of twenty years from the date on which
the application was filed and afford the patentee the right to exclude
others from making, using, offering to sell, or selling the patented
invention in the United States, as well as the right to exclude others from
importing the patented invention into the United States. 54
ANTONY REESE, COPYRIGHT, PATENT, TRADEMARK AND RELATED STATE DOCTRINES 416 (2012)
(providing a historical overview of patent legislation). The Patent Act of 1793 repealed the
Patent Act of 1790. WALTERSCHEID, supra note 48, at 3. Before the Patent Act of 1836, four
other patent acts were passed. Id. The other two main revisions to the patent statute are the
Patent Act of 1870 and the Leahy-Smith America Invents Act (“AIA”) in 2011. MUELLER,
supra note 46, at 33; GOLDSTEIN & REESE, supra note 48, at 416. The Patent Act of 1870
introduced the requirement that patent applicants include claims. MUELLER, supra note 46,
at 33. On the other hand, the AIA modified the patent prosecution process, changed the rules
for the novelty requirement, and revised the priority determination from first to invent to
first inventor to file. GOLDSTEIN & REESE, supra note 48, at 453, 483–84, 562–63.
49
See GOLDSTEIN & REESE, supra note 48, at 418, 419 (indicating that the Patent Act
authorizes utility patents, design patents, and plant patents).
50
See infra Part II.B.1 (describing the different types of patents and outlining the
conditions for patentability).
51
See infra Part II.B.2 (explaining the patent prosecution process).
52
See U.S. Patent Statistics, Calendar Years 1963–2014 (Oct. 23, 2015),
http://www.uspto.gov/web/offices/ac/ido/oeip/taf/us_stat.pdf
[https://perma.cc/
N9QG-T7YY] (reporting the number of patent applications received and granted according
to the type of patent and calendar year). In 2014, the USPTO granted a total of 326,033
patents, 300,677 of which were utility patents. Id.
53
See Design Patent Application Guide, U.S. PAT. & TRADEMARK OFF. (Oct. 26, 2015),
http://www.uspto.gov/patents-getting-started/patent-basics/types-patentapplications/design-patent-application-guide [https://perma.cc/FLJ5-TP4G] (explaining
the differences between design and utility patents); Manual of Patent Examining Procedures
§ 1502.01 (Nov. 2015), http://www.uspto.gov/web/offices/pac/mpep/s1502.html
[https://perma.cc/G9VL-X8XU] (summarizing the differences between utility and design
patents).
54
See 35 U.S.C. § 154(a)(2) (2012) (providing the term of patents); § 271 (establishing the
acts that constitute infringement of a patent); Manual of Patent Examining Procedures § 1502.01,
supra note 53 (stating that for the patents issued on applications filed on or after June 8, 1995,
the term of the patent starts on the date the patent issues, but ends twenty years from the
date on which the patent application was filed). If an application contains a reference to an
earlier filed application or applications under §§ 120, 121, or 365(c), the term of the patent
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To be patentable under a utility patent, the subject matter of an
invention must qualify for a patent and the invention must be new, useful,
and nonobvious.55 The first requirement for patentability is that the
subject matter of the invention qualify as patent-eligible subject matter.56
The types of inventions that qualify as patent-eligible subject matter are
listed in 35 U.S.C. § 101 and are processes, machines, manufactures, and
compositions of matter. 57 Nonetheless, courts have narrowed the
otherwise broad scope of patentable subject matter by recognizing three

ends on the date on which the earliest application was filed. § 154(a)(2).
55
See § 101 (listing the inventions patentable and providing the basis for the utility
requirement); § 102 (establishing the novelty requirement); § 103 (formulating the
nonobviousness requirement). Utility patents must also satisfy the written description and
specification requirements set forth in 35 U.S.C. §§ 111, 112. MUELLER, supra note 46, at 97.
The requirements imposed by 35 U.S.C. § 112 are known as the disclosure requirements and
include the enablement, best mode, and written description of the invention requirements.
Id. These requirements, however, “pertain to the informative quality of the patent
application rather than the technical merits of the claimed invention.” Id. Thus, they are
beyond the scope of this Note. It is sufficient to understand that these disclosure
requirements arise from the quid pro quo contemplated by Congress for granting a patent
monopoly. Id. In other words, the government agrees to give the patentee a limited
monopoly over his or her invention in exchange for a sufficiently detailed and clear
disclosure of the invention. Id.
56
See Manual of Patent Examining Procedures § 2106 (Nov. 2015), http://www.uspto.gov/
web/offices/pac/mpep/s2106.html#d0e197244 [https://perma.cc/P85Z-G97Y] (stating
that a claimed invention must be directed to patent-eligible subject matter); MUELLER, supra
note 46, at 253–55 (discussing potentially patentable subject matter and indicating that
subject matter eligibility refers to the categories of subject matter enumerated in § 101); see
also In re Bilski, 545 F.3d 943, 950 (Fed. Cir. 2008) (“Whether a claim is drawn to patent-eligible
subject matter under § 101 is a threshold inquiry, and any claim of an application failing the
requirements of § 101 must be rejected even if it meets all of the other legal requirements of
patentability . . . .”).
57
See § 101 (providing for the inventions patentable under the Patent Act); see also § 100
(defining “process” as meaning “process, art or method, and includes a new use of a known
process, machine, manufacture, composition of matter, or material”). Courts have
interpreted “manufacture” to mean “the production of articles for use from raw materials
prepared by giving to these materials new forms, qualities, properties, or combinations,
whether by hand labor or machinery.” Am. Fruit Growers, Inc. v. Brogdex Co., 283 U.S. 1,
11 (1931). “Machine” refers to “a concrete thing, consisting of parts, or of certain devices and
combination of devices.” Burr v. Duryee, 68 U.S. 531, 570 (1863). Further, newly developed
plants qualify as patent-eligible subject matter. J.E.M. AG Supply, Inc. v. Pioneer Hi-Bred
Int’l, Inc., 122 S. Ct. 593, 596 (2001); MUELLER, supra note 46, at 288 n.157 (indicating plants
may be eligible for protection under utility patents); General Information about 35 U.S.C § 161
Plant Patents, U.S. PAT. & TRADEMARK OFF. (Oct. 23, 2015), http://www.uspto.gov/patentsgetting-started/patent-basics/types-patent-applications/general-information-about-35usc-161 [https://perma.cc/8P6B-6NF8]. Lastly, “composition of matter” has been construed
as including “all compositions of two or more substances and . . . all composite articles,
whether they be the results of chemical union, or mechanical mixture, or whether they be
gases, fluids, powders, or solids.” Shell Dev. Co. v. Watson, 149 F. Supp. 279, 280 (D.C. Cir.
1957).
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exceptions to § 101.58 These three exceptions are: laws of nature, physical
phenomena, and abstract ideas.59 However, applications of these judicial
exceptions qualify for patent protection. 60 Subject matter eligibility is just
the first hurdle an applicant must clear to patent his or her invention.61
The second statutory requirement is that the invention be new, which
is also known as the novelty requirement.62 The test to determine whether
an invention is new is set forth in 35 U.S.C. § 102(a) and requires
determining whether an invention has been anticipated. 63 An invention
is anticipated, and not novel, if the prior art is identical to the invention. 64
Specifically, a single prior art reference must disclose every element of the
invention.65 Even if a prior art reference does not entirely disclose the
58
See Diamond v. Chakrabarty, 447 U.S. 303, 309 (1980) (clarifying that even though
legislative history supports a broad construction of § 101, it does not follow that § 101 “has
no limits or that it embraces every discovery”).
59
See id. (“[L]aws of nature, physical phenomena, and abstract ideas have been held not
patentable . . . .”). For example, a new mineral discovered in the earth, a new plant found in
the wild, or mathematical formulas are not patentable. Id.
60
See Diamond v. Diehr, 450 U.S. 175, 187 (1981) (“[A]n application of a law of nature or
mathematical formula to a known structure or process may well be deserving of patent
protection.”); Manual of Patent Examining Procedures § 2106, supra note 56 (“While abstract
ideas, physical phenomena, and laws of nature are not eligible for patenting, methods and
products employing abstract ideas, physical phenomena, and laws of nature to perform a
real-world function may well be.”).
61
See supra note 55 and accompanying text (listing all the requirements for patentability).
62
See § 101 (“Whoever invents or discovers any new and useful process, machine,
manufacture, or composition of matter, or any new and useful improvement thereof, may
obtain a patent thereof . . . .”) (emphasis added).
63
See MUELLER, supra note 46, at 138 (indicating that attorneys say an invention has been
anticipated if the novelty provisions of § 102 are triggered). An invention is also not novel if
it was “in public use, on sale, or otherwise available to the public before the effective filing
date of the claimed invention . . . .” § 102(a)(1). The AIA significantly revised Section 102.
Manual of Patent Examining Procedures § 2150 (Nov. 2015), http://www.uspto.gov/web/
offices/pac/mpep/s2150.html [https://perma.cc/8J7E-B89T]. Before the AIA was passed,
§§ 102(a)–(g) established the test for novelty. Id. These provisions still apply to patent
applications filed before March 16, 2013. Id. The most significant change to § 102 under the
AIA is “when and where an event must occur in order to anticipate, and which events will
anticipate . . . .” GOLDSTEIN & REESE, supra note 48, at 457. The changes and the differences
between pre-AIA and AIA § 102, however, are beyond the scope of this Note.
64
See GOLDSTEIN & REESE, supra note 48, at 456 (asserting § 102 bars a patent if the prior
art anticipates the invention, and the prior art anticipates the invention if it is identical to the
invention). Section 102 also specifies what constitutes prior art. See § 102(a)(1) (providing
patents and printed publications are prior art); § 102(b) (denoting what types of disclosures
do not constitute prior art under § 102(a)); § 102(d) (stipulating when a patent is effective as
prior art).
65
See In re Crish, 393 F.3d 1253, 1256 (Fed. Cir. 2004) (stating that determining whether a
claim is anticipated involves two steps: first, interpreting the claim language and second,
comparing the construed claim to prior art references and making factual findings that “each
and every limitation is found either expressly or inherently in that [a] single prior art
reference”); GOLDSTEIN & REESE, supra note 48, at 456 (specifying under § 102, a single prior
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invention, the invention may nonetheless be unpatentable if the
differences would have been obvious to a person having ordinary skill in
the art (“PHOSITA”).66 The third requirement, known as the nonobviousness requirement, deals with such a situation. 67
The non-obviousness requirement for patentability is set forth in § 103
of the Patent Act.68 Under § 103, an invention is not patentable if it was
obvious to a PHOSITA before the effective filing date of the patent
application.69 Thus, the test for obviousness is whether “the differences
between the claimed invention and the prior art are such that the claimed
invention as a whole would have been obvious . . . to a [PHOSITA] to
which the claimed invention pertains.” 70 Even if nonobvious, the
invention may be unpatentable if it does not satisfy the utility
requirement.71

art reference must disclose all the elements of the invention).
66
See Manual of Patent Examining Procedures § 2141 (Mar. 2014), http://www.uspto.gov/
web/offices/pac/mpep/s2141.html [https://perma.cc/753Z-9SAP] (commenting that a
patent may not be obtained, even if the invention is novel under § 102, if the invention would
have been obvious to a person having ordinary skill in the art); MUELLER, supra note 46, at
191–92 (noting the language of § 103 indicates that the obviousness requirement must be
satisfied even if an invention is not anticipated under § 102).
67
See § 103 (providing an invention is not patentable if obvious to person having ordinary
skill in the art (“PHOSITA”)).
68
See id. (establishing the non-obvious subject matter condition for patentability); see also
MUELLER, supra note 46, at 191 (noting the non-obviousness requirement had been
recognized in patent case law since 1851, but was not codified as § 103 until the Patent Act
of 1952).
69
See 35 U.S.C. § 103 (“A patent for a claimed invention may not be obtained . . . if . . . the
claimed invention . . . would have been obvious before the effective filing date of the claimed
invention to a person having ordinary skill in the art . . . .”).
70
Id. See also Graham v. John Deere Co., 383 U.S. 101, 103 (1966) (citing § 103 as providing
the test for obviousness). In Graham, the Supreme Court’s seminal decision concerning
obviousness, the Court set forth the factors to be assessed in determining whether an
invention would have been obvious to a PHOSITA. See MUELLER, supra note 46, at 196
(noting Graham is a landmark opinion); Manual of Patent Examining Procedures, supra note 66,
at § 2141 (describing the recent Supreme Court’s decision in KSR Int’l Company v. Teleflex Inc.,
550 U.S. 398 (2007)), which reaffirmed the obviousness framework set forth in Graham). In
Graham, the court held that the obviousness of the invention is determined by considering:
the scope and content of the prior art, the differences between the prior art and the claims at
issue, and the pertinent level of the ordinary skill in the art. 383 U.S. at 17. Furthermore,
courts can take into account secondary considerations, such as commercial success, long felt
but unsolved needs, and failure of others to solve the need. Id. at 17–18.
71
See § 101 (indicating an invention must be useful to be patentable); but see Lee v. DaytonHudson Corp., 838 F.2d 1186, 1188 (Fed. Cir. 1988) (holding design patents are not subject to
the utility requirement).
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An applicant is not entitled to a patent on his invention unless the
invention is useful.72 An invention is useful if it possesses utility.73
Although the utility requirement is established by 35 U.S.C. § 101, neither
this section nor the Patent Act explains what utility means, and thus, case
law is the source of utility principles.74 Historically, Justice Joseph Story’s
instructions to the jury in Lowell v. Lewis are recognized as the first
articulation of a definition of utility. 75 In charging the jury, Justice Story
stated, “[a]ll that the law requires is, that the invention should not be
frivolous or injurious to the well-being, good policy, or sound morals of
society.”76 This definition came to be known as the “moral-utility
doctrine.”77 Thereafter, Justice Story’s definition would be used to
invalidate patents for lack of moral utility in two types of cases: inventions
to deceive or commit fraud and inventions used for gambling. 78
72
See U.S. CONST. art. I, § 8, cl. 8 (“To promote the progress of science and useful arts, by
securing for limited times to authors and inventors the exclusive right to their respective
writings and discoveries . . . .”) (emphasis added); § 101 (“Whoever invents or discovers any
new and useful process, machine, manufacture or composition of matter . . . may obtain a
patent thereof . . . .”).
73
See MUELLER, supra note 46, at 235 (noting that a useful invention possesses utility).
74
See id. (explaining the Patent Act does not define what useful means, and thus, case law
fills this gap).
75
See Margo A. Bagley, Patent First, Ask Questions Later: Morality and Biotechnology in
Patent Law, 45 WM. & MARY 469, 489 (2003) (“Justice Story is credited with the first
articulation of the [utility] doctrine . . . .”); Andrew R. Smith, Note, Monsters at the Patent
Office: The Inconsistent Conclusions of Moral Utility and the Controversy of Human Cloning, 53
DEPAUL L. REV. 159, 164 (2003) (“Justice Story enunciated the first interpretation of the term
‘useful’ within the 1970 Act.”).
76
Lowell v. Lewis, 15 F. Cas. 1018, 1019 (C.C.D. Mass. 1817). Justice Joseph Story further
explained that the word “useful” was incorporated into the Patent Act “in contradistinction
to mischievous or immoral.” Id. Examples of inventions that would not satisfy the utility
requirement, Justice Story stated, are inventions to poison people, promote debauchery, or
facilitate private assassination. Id. In Lowell, the plaintiff sued the defendant for
infringement of an improvement in the construction of pumps. Id. At issue was the utility
of the invention. Id. The court concluded that the plaintiff’s invention was useful because
there was no evidence that the invention was mischievous. Id. The court further rejected the
defendant’s contention that to satisfy the utility requirement, the plaintiff’s pump had to be
better than previous pumps. Id. Justice Story explained that whether the invention is more
or less useful is immaterial in determining an invention’s utility. Lowell, 15 F. Cas. at 1019.
77
See Bagley, supra note 75, at 490 (asserting Justice Joseph Story’s words in Lowell
provided the foundation for the “moral utility” doctrine); Benjamin D. Enerson, Note,
Protecting Society from Patently Offensive Inventions: The Risk of Reviving the Moral Utility
Doctrine, 89 CORNELL L. REV. 685, 690 (2004) (denoting Justice Story’s definition in Lowell is
referred to as the moral utility doctrine); Gary Gregory, Note, What’s Immoral about Monsanto:
Strengthening the Roots of the Moral Utility Requirement by Amending the U.S. Patent Act, 21
CARDOZO J. INT’L & COMP. L. 759, 771 (2013) (indicating Justice Story’s words in Lowell are
known as the “moral utility requirement”).
78
See Laura A. Keay, Morality’s Move within U.S. Patent Law: From Moral Utility to Subject
Matter, 40 AIPLA Q.J. 409, 412 (2012) (noting Justice Story’s definition was used to invalidate
two types of patents: “gambling devices ‘injurious’ to the moral of society” and “inventions
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More recently, however, since the Supreme Court’s decision in
Brenner v. Manson, courts have defined utility in terms of specific and
substantial utility.79 To begin, in In re Fisher, the Federal Circuit elaborated
on the meaning of specific and substantial utility. 80 Fisher indicated that
to satisfy the substantial utility prong, “an asserted use must show that
that claimed invention has a significant and presently available benefit to
the public.”81 Furthermore, to satisfy the specific utility prong, “an
with a mischievous tendency”); Thomas A. Magnani, The Patentability of Human-Animal
Chimeras, 14 BERKELEY TECH. L.J. 443, 451 (1991) (stating that courts have applied Justice
Story’s definition in two specific cases: inventions used to deceive or commit fraud and
gambling devices and other inventions frowned upon by society). From 1889 to the early
1990s, courts cited some version of Justice Story’s definition of utility to invalidate patents
on gambling-related inventions. Keay, supra note 78, at 412–15. Specifically, courts
invalidated patents for devices that could only be used for gambling purposes or could be
used for other purposes but were currently being used for gambling. Id. For example, in
National Automatic Device Co v. Lloyd, the Northern District of Illinois invalidated a patent
covering a “Toy Automatic Race-Course.” 40 F. 89, 89–90 (C.C.N.D. Ill. 1889). The court
reasoned that the invention lacked utility because, so far, it had only been used for the
“pernicious and hurtful” purpose of gambling. Id. at 90. See also Brewer v. Lichtenstein, 278
F. 512, 513–14 (7th Cir. 1922) (affirming a district court’s decision to dismiss an infringement
action of a patent covering a vending device); Meyer v. Buckley Mfg. Co., 15 F. Supp. 640,
641 (D.C.N.D. Ill. 1936) (invalidating a patent for a vending machine for lack of utility
because it was “a device for playing a game of chance”); Schultze v. Holtz, 82 F. 448, 448–49
(C.C.N.D. Cal. 1897) (invalidating a patent claiming a coin-controlled apparatus); Reliance
Novelty Co. v. Dworzek, 80 F. 902, 903–04 (C.C.N.D. Cal. 1897) (denying a preliminary
injunction in an infringement action of a patent on slot machines because the device lacked
utility). In Reliance Novelty, the court reasoned that the device lacked utility because it had
only been used for gambling purposes. 80 F. at 903. Similarly, in Schultze, the court
concluded the device lacked utility because it had and could only be used for gambling
purposes. 82 F. at 449. Last, in Brewer, the court reasoned that the device lacked utility
because it could only be used as a lottery device. 278 F. at 513. Concerning deceptive
inventions, in Rickard v. Du Bon, the Second Circuit affirmed the district court’s decision to
invalidate a patent claiming a method for treating tobacco leaves to cause spotting. 103 F.
868, 869, 873 (2d Cir. 1990). At the time of the invention, there was a notion among smokers
that spotted tobacco was of higher quality. Id. at 869. The court concluded the invention
lacked utility because it could not improve the quality of the tobacco, and thus, the spotting
was deceiving to buyers. Id. at 872. Further, the court noted that patents could not be granted
on inventions that encouraged profiting by deception and fraud. Id. at 873.
79
See 383 U.S. 519, 534 (1966) (concluding that the “basic quid pro quo contemplated by
the Constitution and the Congress for granting a patent monopoly is the benefit derived by
the public from an invention with substantial utility”). At issue in Brenner was the utility of
a process for making steroids. Id. at 520. Even though the process yielded a steroid closely
related to a steroid with known utility, the court denied the patent for lack of utility. Id. at
534–35. The court concluded that the applicant was unable to show the product that the
process yielded was substantially useful. Id.
80
See 421 F.3d 1365, 1371 (Fed. Cir. 2005) (defining specific and substantial utility). In In
re Fisher, the Federal Circuit affirmed the USPTO Board of Patent Appeals and Interference’s
decision finding claims for “expressed sequence tags” unpatentable for lack of utility. Id. at
1367.
81
Id. at 1371.
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asserted use must also show that that claimed invention can be used to
provide a well-defined and particular benefit to the public.”82
Even though courts have criticized Justice Story’s definition of utility
and expressly rejected the application of the doctrine to gambling and
deceptive devices, no court has expressly foreclosed the application of the
moral utility doctrine to cases outside the realm of gambling and
deceptive devices.83 Scholars, however, propose that the moral utility
Id.
See Smith, supra note 75, at 186 (“Although no judicial opinion has dismissed moral
utility entirely, its direct application to patentable utility is severely limited.”). The decline
of the application of the moral utility doctrine started in 1903, with Fuller v. Berger. Smith,
supra note 75, at 165–66. In Fuller, the Seventh Circuit refused to invalidate a patent covering
a bogus coin detector used to guard gambling machines. 120 F. 274, 274, 278 (7th Cir. 1903).
In finding the device possessed the requisite utility, the court defined utility as requiring that
an invention serve some “beneficial end.” Id. at 275. The Fuller court placed high importance
on the fact that the invention, even though only used in association with gambling devices
at the time, was (1) not originally designed to be used with gambling devices; (2) could be
used for purposes other than with gambling devices; and (3) when used with gambling
devices, it was not connected to the gambling device and thus had no element of chance to
it. Id. at 276. Following this decision, in Chicago Patent Corp. v. Cenco, Inc., the Seventh Circuit
concluded a pin-ball machine was useful because it could not say “as a matter of law” that
the machine was “inherently a gambling device.” 124 F.2d 725, 728 (7th Cir. 1941). Similarly,
the Tenth Circuit, in Callison v. Dean, concluded an amusement device was useful because it
could be used for innocent amusement purposes. 70 F.2d 55, 58 (10th Cir. 1934). Then, in
1947, the Third Circuit applied Justice Story’s definition of utility in Cusano v. Kottler to
conclude that a gaming table satisfied the utility requirement. 159 F.2d 159, 162 (2d Cir.
1947). Although the court took into consideration the gaming aspects of the invention, the
court ultimately reasoned that it was useful because it did not have to be used for gambling
purposes. Id. at 161–62. Subsequently, in Ex parte Murphy, the USPTO Board of Appeals
reversed an examiner’s determination that a slot machine patent lacked utility because it
could only be used for gambling. 200 U.S.P.Q. 80 (P.O. Bd. App. 1977). The Board reasoned
that the USPTO should not be the agency responsible for enforcing morality with respect to
gambling, and thus, concluded “inventions which are useful only for gambling ipso facto”
were not “void of patentable utility.” Id. Thus, Ex parte Murphy expressly rejected the
application of the moral utility doctrine to gambling devices. Id. On the other hand, Whistler
Corp. v. Autotronics, Inc. was the first case that did not apply the doctrine to invalidate patents
covering inventions used to deceive or commit fraud. No. CA3–85–2573–D, 1988 WL 212501,
at *1 (N.D. Tex. July 28, 1988). Here, the court concluded a radar signal detector was useful
despite being used to circumvent the law. Id. Next, in Juicy Whip, Inc. v. Orange Bang, Inc.,
the Federal Circuit held that inventions could not be held unpatentable for lack of utility
“simply because they have the capacity to fool some members of the public.” 185 F.3d 1364,
1368 (Fed. Cir. 1999). Similar to the court’s reasoning in Ex parte Murphy, the court noted that
the utility requirement was not a command to the USPTO or the courts to aid as “arbiters of
deceptive trade practices.” Id. Therefore, Juicy Whip marked the end of the application of
the moral utility doctrine to invalidate inventions designed to deceive or commit fraud. Id.
In Brenner, the court critiqued Justice Story’s definition for two reasons. 383 U.S. at 533. First,
the court explained that, when read narrowly, the definition compelled the court to
determine whether an invention was “frivolous and insignificant,” a task difficult to do. Id.
On the other hand, when read broadly, it would “allow the patenting of any invention not
positively harmful to society.” Id. According to the court, this broad reading gave the word
82
83
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doctrine is no longer good law.84 Nonetheless, courts have not expressly
examined whether morality or illegality should be taken into
consideration when determining whether an invention provides some
specific and substantial benefit to the public under Brenner and In re
Fisher’s definitions.85
In fact, the only time a court has, post-Brenner, alluded to how
illegality would affect the patentability of an invention was in Whistler
Corp. v. Autotronics, Inc.86 Holding that a radar signal detector was
patentable even though the primary and almost exclusive use of the
device was to circumvent law enforcement, the court concluded, “[u]nless
and until detectors are banned outright, or Congress acts to withdraw
patent protection for them, radar detector patentees are entitled to the
protection of the patent laws.”87 Similarly, but before Brenner was
decided, in Fuller v. Berger, the court rejected an accused infringer’s
argument that the court should deny an injunction because the invention
could only be used for illegal purposes under state law. 88 Fuller further
concluded that even though state laws prevented the patentee from
practicing his invention, they did not affect his right to exclude others
from using the invention where legal.89 Nevertheless, neither courts nor
“useful” a meaning Congress did not intend. Id. In In re Fisher, the Federal Circuit stated the
“Supreme Court appeared to reject Justice Story’s de minimis view of utility” in Brenner. 421
F.3d at 1370 (emphasis added).
84
See generally Bagley, supra note 75, at 492 (noting the moral utility doctrine has “suffered
a judicial demise”); Enerson, supra note 77, at 691 (claiming “the moral utility doctrine is not
completely dead”); Gregory, supra note 77, at 762 (arguing for the implementation of a more
strict patent application process that would revitalize the “weakened” moral utility doctrine)
(emphasis added); Cynthia M. Ho, Splicing Morality and Patent Law: Issues Arising from
Mixing Mice and Men, 2 WASH. U. J.L. & POL’Y 247, 249 (2000) (noting no court has relied on
the moral utility doctrine since 1977); Keay, supra note 78, at 411 (indicating the decline of
the moral utility doctrine after its prominence in the twentieth century); Magnani, supra note
78, at 453 (reasoning the moral utility doctrine is defunct based on the district courts’ attitude
towards the doctrine); Dana Visser, Note, Who’s Going to Stop Me from Patenting My SixLegged Chicken? An Analysis of the Moral Utility Doctrine in the United States, 46 WAYNE L. REV.
2067, 2070, 2086 (2000) (observing that the cases on the moral utility doctrine appear
contradictory and it is unclear whether the doctrine has been repudiated).
85
See In re Fisher, 421 F.3d at 1371 (defining specific and substantial utility in terms of
significant, presently available, particular, and well-defined benefit to the public, but
providing no guidance on what should be considered in determining if an invention
provides a benefit to the public).
86
See Civ. A. No. CA3-85-2573-D, 1988 WL 212501, at *1 (N.D. Tex. 1988) (considering the
patentability of a radar signal detector used to circumvent the law). The court held that a
radar signal detector, used primarily to circumvent the law, had patentable utility. Id. The
court reasoned that only Congress could withdraw patent protection for such devices. Id.
87
Id.
88
See Fuller, 120 F. at 275–76 (providing anything used to accomplish a good result is
useful, even if it can be used and is in fact “oftener” used to accomplish bad results).
89
See id. at 279 (“[A] state law which prohibits the use of a certain article, which is
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the USPTO have directly addressed or determined whether an invention
lacks patentable utility if it can be used for illegal purposes. 90
The second type of patents the USPTO grants are design patents.91
Under the Patent Act, “[w]hoever invents any new, original[,] and
ornamental design for an article of manufacture may obtain a patent
therefor . . . .”92 Specifically, design patents protect the ornamental or
aesthetic features of an invention. 93 A design patent has a term of
“fourteen years from the date of grant” and affords the patentee the right
to exclude others from making, using, offering to sell, or selling the
patented design in the United States, as well as the right to exclude others
from importing the patented design into the United States.94 Design
patent applications are subject to the same patentability requirements of
utility patent applications discussed above, except for the utility
requirement.95
patented, is not in derogation of the inventor’s grant under the patent law.”). Most recently,
in Juicy Whip, Inc. v. Orange Bang, Inc., the Federal Circuit reversed a district court’s decision
that a post-mix beverage dispenser designed to look like a pre-mix beverage dispenser was
not useful because its purpose was to increase sales by deception. 185 F.3d 1364, 1368 (Fed.
Cir. 1999). The court indicated “Congress is free to declare particular types of inventions
unpatentable for a variety of reasons, including deceptiveness.” Id. Thus, the court
concluded it could not hold the device unpatentable for lack of utility simply because it had
the capacity to fool consumers. Id. Further, while the court in Juicy Whip, Inc. referred to
Justice Story’s definition when defining utility—also noting that “it has not been applied
broadly in recent years”—it did not expressly reject it. Id. at 1366–67. See also Brenner v.
Manson, 383 U.S. 519, 532–33 (1966) (criticizing Justice Story’s definition of utility for
shedding little light on the issue of utility in the context of chemical process claims); In re
Fisher, 421 F.3d at 1370 (rejecting the applicant’s argument for utility under Justice Story’s
definition).
90
See
Manual
of
Patent
Examining
Procedures
§ 2107.01
(Mar.
2014),
http://www.uspto.gov/web/offices/pac/mpep/s2107.html
[https://perma.cc/SMP7DNXB] (instructing examiners to analyze patentable utility under the principles established
in In re Fisher, but making no mention of morality or illegality in determining an invention’s
benefit to the public); Smith, supra note 75, at 173 (pointing out that it is unclear what effect
the illegality of an invention would have on an evaluation of patentable utility).
91
See GOLDSTEIN & REESE, supra note 48, at 418–19 (2012) (explaining the differences
between the types of patents granted by the USPTO).
92
35 U.S.C. § 171 (2012).
93
See Carman Indus., Inc. v. Wahl, 724 F.2d 932, 939 n.13 (Fed. Cir. 1983) (“Utility patents
afford protection for the mechanical structure and function of an invention whereas design
patent protection concerns the ornamental or aesthetic features of a design.”); Manual of
Patent Examining Procedures § 1502.01, supra note 53 (distinguishing the features utility and
design patents protect).
94
See 35 U.S.C. § 173 (establishing the term of design patents); § 271 (establishing the acts
that constitute infringement of a patent).
95
See § 171 (“The provisions of this title relating to patents for inventions shall apply to
patents for designs, except as otherwise provided.”). Design patent protection does not
extend to features of the design that are functional. See Lee v. Dayton-Hudson Corp., 838
F.2d 1186, 1188 (Fed. Cir. 1988) (“Design patents do not and cannot include claims to the
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The last type of patents the USPTO grants are plant patents.96 Anyone
who “invents or discovers and asexually reproduces any distinct and new
variety of plant . . . may obtain a patent therefor . . . .”97 If granted, the
patent covers the entire plant and lasts for a term of twenty years from the
date on which the application was filed. 98 The patent also affords the
patentee the right to “exclude others from asexually reproducing the
plant, and from using, offering for sale, or selling the plant so reproduced,
or any of its parts[,]” as well as the right to exclude others from “importing
the plant so reproduced, or any parts thereof, into the United States.” 99
Plant patent applications are subject to the same patentability
requirements of utility patent applications discussed above. 100
structural or functional aspects of the article . . . .”). Further, if the design of the invention is
primarily functional, the design lacks ornamentality and is, therefore, not patentable subject
matter under § 171. Design Patent Application Guide, supra note 53. Because design patents
cannot encompass functional features, design patents do not have to satisfy the utility
requirement set forth in § 101. Lee, 838 F.2d at 1188. Nonetheless, design patents must satisfy
the novelty, non-obviousness, application, and specification requirements set forth in §§ 102,
103, 111, and 112. See id. (citing 35 U.S.C. § 171, which indicates that design patents are also
subject to the other patentability requirements outlined in Title 35).
96
See GOLDSTEIN & REESE, supra note 48, at 418–19 (providing the three types of patents
granted by the USPTO).
97
§ 161. The Act includes plant patent protection for “cultivated sports, mutants, hybrids,
and newly found seedlings, other than a tuber propagated plant or a plant found in an
uncultivated state . . . .” Id. A plant is asexually reproduced when a genetically identical
copy of the plant is created without using seeds. General Information about 35 U.S.C § 161
Plant Patents, supra note 57; MUELLER, supra note 46, at 288. Known methods of asexual
reproduction include: tissues culture, layering, granting and budding, and nuclear embryos.
General Information about 35 U.S.C. § 161 Plant Patents, supra note 57. Although not covered
by plant patents, sexually reproduced plant varieties can be protected under the Plant
Variety Protection Act. MUELLER, supra note 46, at 288. However, plants that reproduce
sexually are eligible for plant patent protection if they are asexually reproduced. Manual of
Patent Examining Procedures § 1601 (Nov. 2015), http://www.uspto.gov/web/offices/pac/
mpep/s1601.html [https://perma.cc/T3AS-ED9Y]. Further, both asexually and sexually
reproduced plants are eligible for protection under utility patents. J.E.M. AG Supply, Inc. v.
Pioneer Hi-Bred Int’l, Inc., 534 U.S. 124, 145 (2001). See MUELLER, supra note 46, at 288 n.157
(noting plants may be eligible for protection under utility patents).
98
General Information Concerning Patents, U.S. PAT. & TRADEMARK OFF. (Oct. 23, 2015),
http://www.uspto.gov/patents-getting-started/general-information-concerning-patents#
heading-31 [https://perma.cc/V38L-65QB]. See also supra note 54 and accompanying text
(explaining the starting and ending dates of patent terms in further detail).
99
§ 163. The rights conveyed by a plant patent are limited to a single plant or genome.
General Information about 35 U.S.C. § 161 Plant Patents, supra note 57. Thus, a sport or mutant
of the patented plant does not infringe on the patent. Id. Furthermore, the Federal Circuit
held in Imazio Nursery v. Dana Greenhouses that “the scope of a plant patent is the asexual
progeny of the patented plant variety.” 69 F.3d 1560, 1568 (Fed. Cir. 1995). Therefore, to
establish infringement, the patentee must show that the accused infringer asexually
reproduced the progeny of the “original patented parent plant.” MUELLER, supra note 46, at
289.
100
See General Information about 35 U.S.C. § 161 Plant Patents, supra note 57 (noting the
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In sum, there are three types of patents: utility patents, design patents,
and plant patents.101 To be protected by a patent, an invention or
discovery must satisfy four requirements: it must encompass patenteligible subject matter, and it must be new, useful, and non-obvious.102
The USPTO evaluates whether an invention meets these requirements
during the patent application process, known as the patent prosecution
process.103
2.

Patent Prosecution Process

The process of preparing and filing a patent application, and
thereafter interacting with the patent examiner to obtain the patent, is
called patent prosecution.104 The interaction process between the
applicant and the USPTO begins with the filing of an application. 105 Once
provisions of Title 35 relating to utility patents apply to plant patents and that plant patent
applications “must also satisfy the general requirements of patentability”); Manual of Patent
Examining Procedures § 1602 (Nov. 2015), http://www.uspto.gov/web/offices/
pac/mpep/s1602.html [https://perma.cc/R7TF-SFCW] (indicating the “rules relating to
applications for patent for other inventions or discoveries are also applicable to applications
for patents for plants except as otherwise provided”). The subject matter of a plant patent is
the new asexually reproduced variety. General Information about 35 U.S.C § 161 Plant Patents,
supra note 57. Plant patent applications must also meet the novelty and non-obviousness
requirements. Id. To satisfy the novelty requirement, a plant must “differ from known,
related plants by at least one distinguishing characteristic, which is more than a difference
caused by growing conditions or fertility levels, etc.” Id.
101
See GOLDSTEIN & REESE, supra note 48, at 418–19 (outlining the types of patents granted
by the USPTO).
102
See § 101 (listing patentable subject matter and providing for the utility requirement);
§ 102 (setting forth the novelty requirement); § 103 (establishing the nonobviousness
requirement).
103
See MUELLER, supra note 46, at 42 (explaining what the patent prosecution process is and
how it works); see also infra Part II.B.2 (describing in detail the patent prosecution process).
104
See id. (defining prosecution as “the process of preparing and filing an application in
the USPTO and thereafter interacting with the agency in order to obtain a U.S. patent”).
105
See id. (asserting the prosecution process begins when the application is filed). Two
types of applications can be filed: provisional and nonprovisional applications. Id. General
Information Concerning Patents, supra note 98 (describing the requirements and different types
of applications for a patent). Nonprovisional applications are substantively examined by the
USPTO, while provisional applications are not. See MUELLER, supra note 46, at 43 (noting
provisional applications are not substantively examined); General Information Concerning
Patents, supra note 98 (stating provisional applications are not examined on their merits).
Provisional applications became available on June 8, 1995 with the purpose of lowering the
costs of first patent filings. General Information Concerning Patents, supra note 98. When
submitting a provisional application, contrary to nonprovisional applications, an applicant
is not required to submit claims or an oath of declaration. Id. The only requirement is a filing
fee and a cover sheet indicating the application is provisional in nature. Id. After filing a
provisional application, the applicant has up to twelve months to file a nonprovisional
application. Id. The USPTO will deem the application abandoned if the applicant fails to file
a nonprovisional application. Id. Filing a provisional application provides the applicant
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an application is accepted as complete, a USPTO examiner is assigned to
the application.106
First, the examiner reviews the content of the application and decides
if it meets the requirements of 35 U.S.C § 111(a).107 Next, the examiner
considers whether the invention claimed satisfies the various statutory
requirements for patentability. 108 Depending on the determinations made
by the examiner, the examiner may allow all the claims of the application,
reject all the claims, or allow some claims and reject others. 109 If the
examiner determines the application does not meet one or more of the
requirements, the examiner will explain the reasons for his rejection of the
claims in an office action.110 The applicant has up to six months from the
mailing date on the office action to either amend the claims or to argue
against the objections.111 Thereafter, the examiner reexamines the
with the opportunity to establish an early effective filing date. Id. Meaning the applicant
may rely on the filing date of the provisional application as the priority date for the invention
claimed in the later filed nonprovisional application. MUELLER, supra note 46, at 43. Thus,
in assessing the novelty and nonobviousness of the invention, the examiner is required to
consider only prior art with effective dates earlier that the filling date of the provisional
application. Id. Importantly, the patent, if granted, will expire twenty years from the filing
date of the nonprovisional application—not twenty years from the filing date of the
provisional application. Id. at 44. Hence, the twelve-month period between applications
does not shorten the patent term. Id.
106
See Patent Process Overview, U.S. PAT. & TRADEMARK OFF. (Oct. 27, 2015),
http://www.uspto.gov/patents-getting-started/patent-process-overview
[https://perma.cc/4WMV-L5ZJ] (denoting an application is assigned for examination once
it is accepted as complete). If an application filed is incomplete, the applicant is notified and
given an opportunity to complete the application. Id. If the applicant fails to complete the
application within the specified period, the application is “returned or otherwise disposed
of.” Id.
107
See id. (indicating the examiner reviews the content of the application to determine if it
includes the requirements set forth in 35 U.S.C. § 111(a): a specification, a drawing, and an
oath or declaration); MUELLER, supra note 46, at 45 (explaining an examiner first determines
if the application satisfies the disclosure and claiming requirements).
108
See MUELLER, supra note 46, at 45 (specifying the examiner considers whether the
invention is patentable subject matter, useful, new, and nonobvious).
109
See id. (adding that, depending upon the determinations made by the examiner, he may
allow certain claims and reject others, or allow all the claims or reject all the claims).
110
See id. (noting the examiner conveys and explains all of his determinations to the
applicant in an official document); Patent Process Overview, supra note 106 (“If the examiner
does not think your application meets the requirements, the examiner will explain the
reason(s).”). This is known as the first office action. MUELLER, supra note 46, at 46. It takes
approximately two years after filing the application to receive the first office action. Id.
111
See 35 U.S.C. § 132(a) (2012) (outlining an applicant’s options in response to a notice of
rejection); see also MUELLER, supra note 46, at 46 (stating an applicant has a period of six
months to respond to the first office action); Patent Process Overview, supra note 106
(indicating the applicant has an opportunity to amend the claims or “argue against the
examiner’s objections”). If the applicant does not respond to the office action within the
required time, the application is deemed abandoned. Patient Process Overview, supra note
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application and issues a second office action, which is known as the Final
Action.112 In the response, the applicant must overcome all the
objections.113 Nonetheless, if the Final Action rejects a claim for a second
time or the applicant disagrees with the rejections, the applicant may
appeal to the Patent Trial and Appeal Board (“PTAB”), file a request for
continued examination (“RCE”), or file a “continuing application.”114 If at
any time during the process the examiner determines the invention is
entitled to a patent, the examiner will issue a Notice of Allowance. 115
Approximately three months after the applicant pays for an issuing fee,
the USPTO will issue the patent.116
C. Marijuana and Patent Law
There are a wide variety of inventions the marijuana industry could
seek to protect under design, plant, or utility patents. First, inventors
could apply for design patents to protect the ornamental designs of items
used in the marijuana industry.117 Second, inventors could apply for plant
106. Specifically, in the response, the applicant may “traverse” the rejections or narrow the
scope of the claims to overcome the rejection. See id. (noting that when responding to the
examiner’s rejections, the applicant can make arguments for patentability (“traverse”) to
overcome the rejection or narrow the scope of the claims by amending them to avoid the
prior art). When the applicant attempts to traverse a rejection, the applicant submits
evidence in support thereof. Id. The applicant may change the wording of the claims, add
new claims, or amend the written description as long as no new matter is added. Id.
112
See MUELLER, supra note 46, at 47 (asserting the examiner reexamines the application
once the applicant responds to the first office action). Like the first office action, the Final
Action can allow all the claims of the application, reject all the claims, or allow some of the
claims and reject others. Id.
113
See Patent Process Overview, supra note 106 (providing an applicant has to overcome all
of the examiner’s rejections in his response to a Final Action). This time, however, the
applicant cannot argue against the objections. See MUELLER, supra note 46, at 47 (indicating
an applicant cannot argue the rejections asserted in a Final Action).
114
See § 134 (“An applicant for a patent, any of whose claims has been twice rejected, may
appeal from the decision of the primary examiner to the Patent Trial and Appeal Board,
having once paid the fee for such appeal.”); MUELLER, supra note 46, at 47 (stating that after
the Final Action, an applicant can request for continued examination or file a second or
“continuing” application). Requests for continued examinations (“RCEs”) and “continuing”
applications are beyond the scope of this Note; however, see MUELLER, supra note 46, at 47–
48 for a detailed explanation of these options.
115
See § 151 (noting the Office issues a Notice of Allowance when the applicant is entitled
to a patent); see also MUELLER, supra note 46, at 48 (“Whenever in the process the examiner
determines that the applicant is entitled to a patent on some or all of the claims, he will send
the applicant a Notice of Allowance so indicating.”).
116
See MUELLER, supra note 46, at 48 (indicating the applicant must pay an issue fee within
three months to obtain the patent).
117
See Neil Juneja, Patent Law in the Marijuana Industry, MARIJUANA VENTURE (Nov. 20,
2014),
http://www.marijuanaventure.com/patent-law-marijuana-industry/
[https://perma.cc/Z8VA-8SZN] (noting bongs, vaporizers, packaging for edibles, and
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patents to protect newly developed varieties of the marijuana plant, like
the patent Holmes is requesting for his Otto II medical-grade marijuana
strain.118 Third, inventors could seek utility patents having claims
directed to either marijuana plants or marijuana-related technologies.119
Marijuana plants themselves are also protectable under a utility patent. 120
There are two legality concerns surrounding patent applications
claiming marijuana strains or marijuana-related inventions, relating to the
use and subject matter of the invention. 121 First, some of the inventions
can be used only for illegal purposes under federal law.122 Specifically,
inventions particularly designed to be used in association with marijuana,
and that can only be used for such purpose, would only be useful for
illegal purposes.123 Nonetheless, some of the inventions can be used
marijuana-related glassware are among the products that could be protected under design
patents).
118
See Blevins, supra note 1 (telling Ben Holmes’s story and his desire to obtain a patent
protecting his Otto II medical–grade marijuana strain which, if granted, would be the first
marijuana plant patent); see also Victoria Slind-Flor, Roche, Marijuana, Bakken, MakeMyTrip:
Intellectual Property, BLOOMBERG BUS. (Jan. 5, 2015), http://www.bloomberg.com/
news/articles/2015-01-05/roche-bakkken-fleetmanager-makemytrip-intellectual-property
[https://perma.cc/4MQR-K84K] (noting a Colorado marijuana seed producer has applied
for the first U.S. plant patent for marijuana).
119
See Juneja, supra note 117 (providing that methods for breeding and producing specialty
cannabis, software systems for managing cannabis crops, methods for infusing products
with marijuana and the machines used in the process, methods of making edibles, and
cannabis extraction devices are among the technologies that could be protected with a utility
patent); see also Pat. App. No. 20150165030 (June 9, 2016), http://www.google.com/patents/
US20150165030 [https://perma.cc/289X-NABL] (describing an application for a “Method
for Making and Storing Stable Cannabinoid Compositions and Method for Treatment Using
Such Compositions”).
120
See J.E.M. AG Supply, Inc. v. Pioneer Hi-Bred Int’l, Inc., 534 U.S. 124, 145 (2001) (holding
both asexually and sexually reproduced plants are eligible for protection under utility
patents); MUELLER, supra note 46, at 288 n.157 (noting plant-related inventions qualify as
patentable subject matter under 35 U.S.C. § 101); General Information about 35 U.S.C. § 161
Plant Patents, supra note 57 (asserting the USPTO accepts utility patent applications with
claims to plants and seeds); Manual of Patent Examining Procedures § 2105, (Mar. 2014),
https://www.uspto.gov/web/offices/pac/mpep/s2105.html [https://perma.cc/QYF4JRTQ] (indicating patentable subject matter under 35 U.S.C. § 101 includes plant breeds).
121
See Matthew Sean Tucker, Useful Patent for Some Legitimate Purpose, TUCKER IP (Dec. 6,
2013), http://www.tuckeriplaw.com/useful-patent/ [https://perma.cc/7D93-LDZR] (“If
the invention claimed by the patent application can only be used for an illegal purpose under
federal law, then the invention would likely be interpreted by the patent office [as] lacking
utility, i.e., lacking usefulness, and therefore be rejected.”); see also Davis, supra note 8
(explaining some lawyers think the USPTO is “unlikely to allow patent protection for a
substance the federal government has deemed illegal”).
122
See Blevins, supra note 1 (reporting the USPTO has rejected cannabis-related patents
because the invention has no useful purposes since its use violates federal law); see also
Tucker, supra note 121 (commenting a “crafty” patent attorney should be able to obtain a
marijuana-related patent if she describes and claims non-illegal uses for the invention).
123
See Tucker, supra note 121 (“[A] machine specifically designed—and having only one
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outside the marijuana industry.124 Second, the subject matter of some
marijuana-related inventions is illegal; meaning the invention itself is
illegal.125 Finally, in some cases, the application claims illegal subject
matter and practicing the invention is illegal.126
Interestingly, the USPTO has already issued patents that involve
chemicals isolated from the marijuana plant, as well as patents covering
smoking paraphernalia.127 This suggests the USPTO is willing to issue
patents “around the edges of marijuana.” 128 However, attorneys argue
that the USPTO will not be as willing to grant a patent claiming the plant
itself or a patent protecting an invention that can only be used in
relationship with marijuana.129 Therefore, plant patents and utility

purpose—to cultivate [a] new [marijuana] strain would not be patentable.”). For example, a
method of cultivating a specific marijuana strain that would only work for cultivating that
specific marijuana strain is only useful for the illegal activity of growing marijuana.
124
See Juneja, supra note 117 (stating for example, bongs and vaporizers can be used with
legal products, such as oils or tobacco).
125
See Davis, supra note 8 (stating attorneys believe the USPTO will not allow patents
protecting a substance that is illegal under federal law); Forest, Cannabis: Patently Useless?,
DRUG L. & POL’Y (Feb. 25, 2015), https://druglawandpolicy.wordpress.com/2015/02/25/
cannabis-patently-useless/ [https://perma.cc/GA3G-NPR2] (questioning whether the
USPTO would be willing to grant patents on something that is illegal). One example is a
patent claiming a strain of cannabis. See Blevins, supra note 1 (reporting the USPTO has
rejected cannabis-related patents because marijuana is illegal); Davis, supra note 8 (quoting
attorney David Resnick from Nixon Peabody LLP, who thinks the USPTO will say: “[T]his
is illegal under federal law, and we’re not going to promote it . . . .”). The marijuana strain,
the subject matter of the invention, is in and of itself illegal. See supra note 8 and
accompanying text (explaining marijuana is a Schedule I substance, and thus,
manufacturing, distributing, dispensing, or possessing marijuana is illegal). Another
example is a method for breeding specialty cannabis, since the subject matter of the
invention, breeding cannabis, is illegal. See id. (noting it is illegal to manufacture marijuana).
126
See Tucker, supra note 121 (explaining a machine specifically designed to cultivate
marijuana would not be patentable). An application claiming a method for cultivating a
specific marijuana strain that would only work for cultivating that specific marijuana strain,
would be useful for illegal purposes and its subject matter—cultivating marijuana strains—
would also be illegal. See 21 U.S.C. § 841 (2012) (exemplifying it is illegal to manufacture and
posses marijuana).
127
See Patent Application Full Text and Image Database, U.S. PAT. & TRADEMARK OFF. (Oct. 28,
2015), http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u
=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=marijuana&FIELD1
=&co1=AND&TERM2=cannabis&FIELD2=&d=PG01
[https://perma.cc/F9FU-XB2H]
(listing all the marijuana-related patent applications pending at the USPTO); Patents Related
to Cannabis, CANNABIS RES. A TO Z (Oct. 28, 2015), http://www.calgarycmmc.com/
cannabispatents.htm [https://perma.cc/QF2S-LQEP] (listing patents related to cannabis
that have issued between 2000–2013).
128
Davis, supra note 8. For example, the office might be willing to grant a patent on a
software system for managing marijuana crops. Id.
129
See supra note 8 and accompanying text (suggesting the USPTO would not be willing to
grant patents on inventions without any legal uses).
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patents with claims directed to the plant “face [the] tough[est] road at [the]
USPTO.”130
III. ANALYSIS
Recently, the USPTO started receiving applications for patents
seeking to protect new strains of marijuana and marijuana-related
technologies.131 These applications have followed state legislative
decisions legalizing marijuana for medical and recreational use.132
However, marijuana remains illegal under federal law, and thus, many
attorneys argue it is unlikely the USPTO will issue patents protecting
marijuana-related inventions.133
This Part of the Note analyzes the patentable utility of marijuanarelated inventions and suggests illegality should not affect the patentable
utility of an invention.134 First, Part III.A examines the grounds of rejection
that the USPTO could assert to deny marijuana-related patent applications
for lack of patentable utility based on the drug’s classification as an illegal
substance under federal law.135 Second, Part III.B analyzes case law to
determine whether there is a sufficient legal basis for a rejection for lack
130
See Davis, supra note 8 (discussing why marijuana plant patents “face [a] tough road at
[the] USPTO”).
131
See Blevins, supra note 1 (telling Ben Holmes’s story and describing his plant patent
application for Otto II, a medical-grade marijuana strain); Davis, supra note 8 (indicating the
USPTO has received patent applications seeking to protect new types of marijuana plants);
Pat. App. No. 20150165030, supra note 119 (claiming a “Method for Making and Storing
Stable Cannabinoid Compositions and Method for Treatment Using Such Compositions”);
Patent Application Full Text and Image Database, supra note 127 (providing a list of all the
marijuana-related patent applications pending before the USPTO).
132
See Davis, supra note 8 (noting the USPTO started receiving patent applications relating
to marijuana plants after Colorado and Washington legalized the recreational use of
marijuana); see generally State Medical Marijuana Laws, supra note 6 (reporting a total of
twenty-three states and the District of Columbia and Guam have legalized the use of
marijuana for medical use); Todd Garvey & Brian T. Yeh, State Legalization of Recreational
Marijuana:
Selected Legal Issues,
CONG. RES. SERV. (Jan. 13, 2014),
http://www.fas.org/sgp/crs/misc/R43034.pdf [https://perma.cc/DT32-YESK] (stating
Colorado and Washington became the first states to legalize marijuana for recreational use).
133
See Davis, supra note 8 (citing intellectual property attorneys that argue the USPTO will
not issue patents protecting an illegal substance, including David Resnick of Nixon Peabody
LLP, John Dragseth of Fish & Richardson PC, and Douglas Sorocco of Dunlap Codding). But
see id. (noting other attorneys have pointed out that “simply because something is illegal
does not make it ineligible for a patent and that patents on marijuana strains may be
permissible”).
134
See infra Part III.A–B (evaluating the possible grounds of rejection the USPTO could
potentially assert in denying marijuana-related patent applications and the legal basis for
these grounds).
135
See infra Part III.A (considering the arguments the USPTO could assert to deny
marijuana-related patent applications).
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of patentable utility based on an invention’s illegality. 136 Next, Part III.C
applies the legal basis evaluated in Part III.B to marijuana-related patent
applications to determine whether they have patentable utility. 137 Last,
Part III.D proposes even though the USPTO may have sufficient legal
basis to reject marijuana-related inventions for lack of utility based on
marijuana’s classification as an illegal substance, illegality should not play
a role in patent law.138
A. Grounds of Rejection the USPTO Could Assert to Deny Marijuana-Related
Patent Applications
The USPTO could potentially deny marijuana-related patent
applications for failure to satisfy any of the patentability requirements:
patent-eligible subject matter, novelty, utility, and non-obviousness.139
However, this Note only focuses on grounds of rejection for lack of
patentable utility based on marijuana’s status as a controlled substance
under federal law.140 Under In re Fisher, an invention must provide a
significant, presently available, well-defined, and particular benefit to the
public to satisfy the utility requirement.141 Accordingly, the USPTO could
assert that marijuana-related inventions lack utility because they provide
no benefit to the public.142 In making this argument, the USPTO would
136
See infra Part III.B (examining the legal basis for the arguments the USPTO could assert
to deny marijuana-related patent applications).
137
See infra Part III.C (analyzing the role of illegality and morality in patent law).
138
See infra Part III.D (concluding illegality and morality do not and should not play a role
in patent law).
139
See supra note 110 and accompanying text (indicating a patent application can be denied
for failure to satisfy any of the patentability requirements).
140
See infra Part III.A (discussing grounds of rejection for failure to satisfy the utility
requirement). Historically, immoral patents were invalidated for lack of patentable utility
pursuant to the moral utility doctrine. See supra note 78 and accompanying text (discussing
the moral utility doctrine case law).
141
421 F.3d 1365, 1371 (Fed. Cir. 2005) (defining utility in terms of substantial and specific
utility); see also Brenner v. Manson, 383 U.S. 519, 534 (1966) (“The basic quid pro quo
contemplated by the Constitution and the Congress for granting a patent monopoly is the
benefit derived by the public from an invention with substantial utility.”) (emphasis added).
Douglas J. Sorocco, a director and shareholder at Dunlap Codding, also suggests marijuanarelated applications “will be highly scrutinized as to the scope and quality of disclosure and
many marijuana companies may find that the patent office will judge their applications
scientifically inadequate . . . .” See Ciccatelli, supra note 7 (interviewing Sorocco regarding
the patentability of marijuana plants).
142
See supra Part II.B.2 (providing an overview of the patent prosecution process and
explaining that a patent examiner will determine whether the patent application satisfies all
the patentability requirements, including the utility requirement); see generally Tucker, supra
note 121 (“If the invention claimed by the patent application can only be used for an illegal
purpose under federal law, then the invention would likely be interpreted by the patent
office as lacking utility . . . .”); Davis, supra note 8 (noting the USPTO could cite the drug’s
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rely on the federal government’s classification of marijuana as an illegal
substance and contend the public can derive no benefit from the invention
because either the invention itself is illegal or practicing the invention
would be illegal.143
However, an invention only needs to have one legitimate use to satisfy
the utility requirement.144 To counter the USPTO’s argument, an applicant
could argue that the invention satisfies the utility requirement because
using the invention would be legal in the states that have legalized
marijuana; therefore, the invention would have at least one legitimate
use.145 The USPTO would have two rebuttal arguments. First, the USPTO
could point out federal law trumps state law, and thus, in the Office’s eyes,
marijuana-related inventions are illegal and can only be used for

classification as illegal to reject an application for a marijuana-related patent).
143
See supra Part II.B.2 (indicating that when an examiner determines a patent application
fails one of the statutory requirements for patentability, the examiner will explain the reasons
for such failure in an Office Action); see also supra note 121 and accompanying text (explaining
why marijuana related inventions could serve illegal purposes). For example, if the
application relates to a technology that will be used in association with marijuana, such as a
method for breeding and producing specialty cannabis, the USPTO would claim the
invention provides no benefit to the public, and thus, lacks utility because the invention will
be used for illegal purposes. See 21 U.S.C. § 841 (2012) (criminalizing the possession and
manufacturing of marijuana). On the other hand, if the application is either a plant patent
application or a utility application with claims directed to a plant, for example, a method for
using a certain amount of cannabinoid to treat a disease, the USPTO would argue the
invention provides no benefit to the public, and thus, lacks utility because the invention itself
is illegal. See § 812 (listing marijuana as a controlled substance). The invention itself would
be illegal because manufacturing or possessing “any material, compound, mixture, or
preparation, which contains any quantity of [marijuana], or which contains any of [its] salts,
isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of
isomers is possible,” is unlawful. §§ 812, 841. Furthermore, for applications of the latter type
that specifically claim a medical benefit, the USPTO would have an even stronger argument
because marijuana’s classification under federal law as a Schedule I substance is made on a
determination that it has “no currently accepted medical use.” § 812. Accordingly, the utility
claimed by the applicant would be non-existent in the eyes of the USPTO, a federal agency.
But see Davis, supra note 8 (noting attorneys have pointed out “simply because something is
illegal doesn’t make it ineligible for a patent and that patents on marijuana strains may be
permissible”).
144
See Juicy Whip, Inc. v. Orange Bang, Inc., 185 F.3d 1364, 1366 (Fed. Cir. 1999) (“An
invention is ‘useful’ under Section 101 if it is capable of providing some identifiable
benefit.”); Fuller v. Berger, 120 F. 274, 275 (7th Cir. 1903) (“[E]verything [is] useful within the
meaning of the law, if it is used (or is designed and adapted to be used) to accomplish a good
result, though in fact it is oftener used (or is as well or even better adapted to be used) to
accomplish a bad one . . . .”); see also Smith, supra note 75 (explaining that following the
Seventh Circuit’s decision in Fuller v. Berger, courts would find that an invention satisfies the
utility requirement if the device has legal uses).
145
See NAT’L CONF. OF ST. LEGIS., supra note 6 (noting a total of twenty-three states and the
District of Columbia and Guam have legalized the use of marijuana for medical use).
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illegitimate purposes.146 Second, even if federal law did not trump state
law in this case, the rights conveyed by a patent are established under
federal law.147 Accordingly, the USPTO could argue it has no choice but
to accept Congress’s determination that marijuana has no recognized
benefit to the public and no legitimate purpose or use, so long as
marijuana remains a Schedule I substance under federal law.148
Even though the USPTO’s contentions sound persuasive, they are
entirely hypothetical because neither the USPTO nor courts have had to
determine whether an invention lacks patentable utility because its subject
matter or its use is illegal under federal law while legal under state laws.149
Accordingly, Part III.B examines existing case law to determine whether
the USPTO or courts would have sufficient legal basis for denying
applications because an invention lacks legal utility. 150
B. What Is the Legal Basis for Denying or Invalidating Patents for Lack of
Moral or Legal Utility?
Neither courts nor the USPTO have had to determine whether an
invention lacks patentable utility because its subject matter and/or its use
is illegal under federal law while legal under state laws.151 Accordingly,
See Blevins, supra note 1 (“[F]ederal law trumps state law.”).
See § 1338(a) (granting district courts original jurisdiction over civil actions “arising
under any Act of Congress relating to patents” and denying state courts jurisdiction over
claims for relief “arising under any Act of Congress relating to patents”); see also Margo A.
Bagley, The New Invention Creation Activity Boundary in Patent Law, 51 W. & MARY 577, 606
(2009) (“The right to exclude granted to a patentee is a right granted under the federal patent
laws.”).
148
See Davis, supra note 8 (noting the USPTO could “expressly cite the classification of the
drug as illegal” to reject an application for a patent on the marijuana plant).
149
See id. (“[T]here has never been a precisely analogous situation where a substance is
legal in some states, but still technically illegal nationwide.”); see also Smith, supra note 75
(noting federal courts have never addressed what effect, if any, outright illegality or banning
of the subject matter of an invention by Congress would have on the determination of
patentable utility); infra Part III.A.1–2 (discussing the possible legal basis the USPTO could
rely on to reject patents on illegal subject matter and explaining how the cases are not on
point). According to a Vice News article, “[a] spokesperson for the US Patent and Trade
Office confirmed that officials are now accepting and processing patent applications for
individual varieties of cannabis, along with innovative medical uses for the plant and other
associated inventions.” Walters, supra note 1. The article further indicated the spokesperson
noted “no special statutory requirements or restrictions applied to marijuana plants.” Id.
150
See infra Part III.B.1 (evaluating the legal grounds for a rejection for lack of legal utility).
151
See supra note 85 and accompanying text (noting uncertainties regarding illegality and
patentable utility); see also In re Fisher, 421 F.3d 1365, 1371 (Fed. Cir. 2005) (specifying that
under the utility standards set forth in Brenner, specific and substantial utility refers to a
significant, presently available, particular, and well-defined benefit to the public, but
providing no guidance on what should be considered in determining if an invention
provides a benefit to the public).
146
147

https://scholar.valpo.edu/vulr/vol51/iss3/5

Carmona: Dude, Where's My Patent?: Illegality, Morality, and the Patentabi

2017]

Patentability of Marijuana

679

there is no federal court precedent directly applicable to this rejection. 152
Nonetheless, some of the cases on the moral utility doctrine’s application
to gambling devices provide important insight as to what would be the
effect of a declaration of illegality by Congress on the evaluation of
patentable utility.153 Consequently, this Part examines relevant moral
See Manual of Patent Examining Procedures § 2107.01, supra note 90 (indicating patentable
utility is analyzed under the principles established in In re Fisher, without mentioning
whether morality or illegality has to be considered when determining the invention’s benefit
to the public); Smith, supra note 75, at 173 (noting that the effect of illegality on an evaluation
of patentable utility is unknown).
153
See supra notes 86–90 and accompanying text (discussing Fuller, Whistler, and Juicy Whip,
three moral utility doctrine cases that allude to what would be the effect of illegality on the
patentability of an invention). There is no analysis of the grounds of rejection under the
moral utility doctrine because it is assumed the doctrine is dead and courts and the USPTO
are not willing to revive the doctrine, as evidenced by the USPTO’s reluctance to apply the
doctrine when it had the opportunity, and the Manual of Patent Examining Procedure’s
(“MPEP’s”) adherence to In re Fisher’s definition of patentable utility. See supra note 84 and
accompanying text (outlining scholarly articles discussing why the moral utility doctrine is
no longer good law). Starting in the late 1990s, the USPTO and the courts had several
opportunities to deny or invalidate patents on controversial inventions by invoking the
moral utility doctrine. Smith, supra note 75. The first opportunity arose in 1998 when an
inventor filed an application involving “chimeric embryos that contained both human and
nonhuman cells.” Id. The filing of the patent application attracted national media attention
and “focused on the moral issue implicated by the[] proposed human-animal hybrids.”
Keay, supra note 78. While the USPTO initially responded by issuing a press release
indicating human-animal chimeras were not patentable because, “among other things, they
would fail to meet the public policy and morality aspects of the utility requirement,” the
Office later retracted its stance. Smith, supra note 75. Instead, the Office rejected the
application on the ground that it constituted non-eligible subject matter. Keay, supra note
78; Smith, supra note 75. The human-animal chimera patent application was followed by
countless controversial applications in the field of biotechnology that included methods for
cloning, embryos containing both human and nonhuman cells, and a variety of gene patents.
See Smith, supra note 75 (discussing the controversies with human cloning patent
applications); Keay, supra note 78 (analyzing controversial applications in the field of
biotechnology). In rejecting or granting these applications, the USPTO made no reference to
morality. See Smith, supra note 75 (noting that the USPTO rejections were on grounds of
ineligible subject matter); Keay, supra note 78 (describing the USPTO’s rejections under
subject matter eligibility grounds). The fact that the Office had several opportunities to reconsider morality in patentable utility, but did not, demonstrates that the office is not
comfortable with rejecting patents on such grounds. See Smith, supra note 75 (noting the
USPTO is not comfortable rejecting patents on a moral basis). Further, the MPEP, which
outlines the laws and regulations followed by the USPTO when examining patent
applications, makes no reference to morality or Justice Story’s definition of utility. See
Manual of Patent Examining Procedures § 2107, supra note 90 (indicating the MPEP does not
“constitute substantive rulemaking and hence do[es] not have the force and effect of the
law”); In re Fisher, 421 F.3d at 1372 (noting courts are willing to give the MPEP “judicial
notice” to the extent it does not conflict with the Patent Act); MUELLER, supra note 46, at 34
(explaining that the MPEP is very useful in understanding the way the USPTO approaches
patentable utility). Most likely, if the USPTO would have wanted to leave the door open to
the application of the moral utility doctrine in the future, or for considering public morals
152
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utility doctrine precedent to determine what would be the legal basis for
rejections based on a declaration of illegality by Congress.154
The moral utility doctrine was historically used to invalidate
gambling and deceptive inventions. 155 When it came to patents covering
gambling devices, while courts referred to the immorality of gambling to
invalidate the patents, the courts’ reasoning was closely related to strong
anti-gambling state laws of the time. 156 Thus, these cases were concerned
with illegality as well as morality.157
The first important insight on a possible rejection for lack of legal
utility is provided in Fuller.158 Fuller explained that state laws preventing
the patentee from practicing his invention did not affect his right to
exclude others from using the invention where legal. 159 The court’s
conclusion appears to suggest that state laws affecting the legality of use
of an invention should not affect the patentability of the invention. 160
when determining patentable utility, it would have included it in the Guidelines.
154
See infra Part III.B (determining that a federal declaration of illegality would affect
patentable utility in limited circumstances).
155
See supra note 78 and accompanying text (examining cases applying the moral utility
doctrine to gambling and deceptive devices and tracing the evolution of the doctrine).
156
See Keay, supra note 78 (“Moral opposition to gambling in the United States was highest
around the same time courts were invalidating patents for gambling devices . . . and two
strong waves of anti-gambling sentiment led to near prohibition of gambling activities” in
the twentieth century); see generally, Roger Dunstan, History of Gambling in the United States
(Oct. 30, 2015), http://www.library.ca.gov/crb/97/03/chapt2.html [https://perma.cc/
E3AA-2TLE] (examining the history of gambling in North America); George G. Fenich, A
Chronology of (Legal) Gaming in the U.S., 30 GAMING RES. & REV. J. 65
http://digitalscholarship.unlv.edu/cgi/viewcontent.cgi?article=1223&context=grrj
[https://perma.cc/WKS6-TM2Q] (providing a timeline of the development of gaming in the
U.S.); G. Robert Blakey & Harold A. Kurland, The Development of the Federal Law of Gambling,
63 CORNELL 923, 927–58 (1978) (detailing the history of the evolution of federal gambling
laws); see also Fuller v. Berger, 120 F. 274, 179–82 (7th Cir. 1903) (Grosscup, dissenting)
(examining the morality of gambling).
157
See Fuller, 120 F. at 179–282 (invalidating a gambling-related patent for want of utility
based on laws prohibiting gambling and social perceptions that gambling was immoral).
158
See id. at 276 (holding that a bogus-coin detector used with gambling devices did not
lack patentable utility simply because it could be used with gambling devices). The court
indicated courts should not void patents for want of utility if the defendant proves the
invention has been used to accomplish bad results if the court can be convinced the invention
can be used to achieve positive results. Id.
159
See id. at 279 (“[A] state law which prohibits the use of a certain article, which is
patented, is not in derogation of the inventor’s grant under the patent law.”). The court
rejected the accused infringer’s argument that the court should deny an injunction because
the invention could only be used for illegal purposes under state law. Id. The court noted
that a device had the requisite utility if it could be used for a good purpose, even if it is most
often used to accomplish negative results. Id. at 275. Fuller provided several examples of
devices that have positive and negative purposes, including the colt revolver, steam engines,
dynamos, and electric railroads. Fuller, 120 F. at 275–76.
160
See id. (“[T]he state law operated wholly upon the inventor’s natural right to the use of
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However, at the time Fuller was decided, gambling, although highly
regulated under federal law, was only illegal under most state laws. 161
Thus, Fuller’s conclusion, when analyzed in context, is arguably limited to
the patentability of inventions that have illegal uses under state laws, but
permitted uses under federal law.162 Further, the laws at issue in Fuller
concern only the legality of use of an invention. 163 Fuller’s holding is,
therefore, only informative on the patentability of inventions that have
illegal uses and sheds no light on the patentability of inventions whose
subject matter is illegal in some states, but legal in others.164 Thus, while
Fuller’s holding is instructive on the patentability of an invention that can
be used for illegal purposes under state laws, it is impossible to discern
whether the court’s opinion would change if federal laws also made the
use illegal.165
Nonetheless, Whistler Corporation v. Autotronics, Inc. is informative on
the effect a federal ban could have on a determination of patentable
utility.166 In Whistler, the court held that a radar signal detector primarily
used to circumvent the law was patentable, instructing, “[u]nless and until
detectors are banned outright, or Congress acts to withdraw patent
protection for them, radar detector patentees are entitled to the protection
of the patent laws.”167 Whistler’s reference to an “outright ban” on the
subject matter of the invention, the detector, suggests that an invention

his property, and not at all upon the franchise which the patent grants, which consists
altogether in the right to exclude.”) (emphasis added). Fuller reasoned that state laws that
affected the use of the patented article did not affect the rights granted on the patentee
because patent law grants exclusionary rights. Id.
161
See supra note 156 and accompanying text (examining the state of gambling laws at the
time the moral utility doctrine was used to invalidate patents covering gambling devices).
162
See supra note 8 and accompanying text (explaining medical and recreational marijuana
is legal in some states but is illegal under federal law, and because patent rights are
established under federal law, it is unclear whether the USPTO will issue patents protecting
marijuana plants and marijuana-related inventions). At the time Fuller was decided, all
states but New Mexico had prohibited gambling. Fuller, 120 F. at 279. Nonetheless, the
federal government had not banned gambling, it simply regulated it. Supra note 156 and
accompanying text.
163
See Fuller, 120 F. at 279 (noting that gambling laws affected the inventor’s right to use
the invention and not the right to exclude others).
164
See id. at 279–80 (examining the patentability of a gambling device at a time in history
where gambling was illegal under state laws but permitted under federal law).
165
See id. at 276 (holding that an invention that could be used in association with gambling
devices did not lack patentable utility despite state laws banning gambling).
166
See No. CA3–85–2573–D, 1988 WL 212501, at *1 (N.D. Tex. July 28, 1988) (finding that
whether a device used to circumvent the law is patentable is a matter “for the legislatures of
the states, or for the Congress, to decide[,]” not the court).
167
See id. (noting only two states have prohibited such devices).
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would lack patentable utility if its subject matter were illegal under federal
law.168
Whistler is also informative on whether the patentable utility of an
invention would be affected if the invention is useful for purposes banned
by Congress but the invention’s subject matter is not banned. 169 It may be
inferred, from the court’s reasoning when scrutinizing the court’s choice
of words in light of the alleged infringer’s arguments, that the
patentability of an invention is not affected by a federal or state ban on the
use of the invention, so long as the subject matter of the invention is not
federally banned. Notice the alleged infringer argued that the radar was
not patentable because it was used for an illegal purpose—to circumvent
the law.170 The alleged infringer did not argue the invention itself was
illegal—only its application.171 Yet, the court’s reasoning focused on a ban
by Congress on the subject matter of the invention and not its application.172
This suggests the court is not concerned with the legality of an invention’s
applications but with the legality of the invention’s subject matter. 173
Thus, it appears the court would reason that an invention has patentable
utility even if it is useful for purposes banned by Congress, as long as its

168
See id. (explaining that even though two states have prohibited the use of radar signal
detectors, the court cannot withdraw patent protection from such devices until Congress
does so because that is a matter for the legislatures of the states or for Congress to decide).
169
See id. (concluding a radar detector used primarily and exclusively for the illegal
purpose of circumventing the law was patentable until Congress banned these devices).
170
See id. (commenting in response to the defendant’s defense of lack of utility, the court
below noted the “incongruity” of the plaintiff’s request to protect a device used to
circumvent the law). Plaintiff presented evidence that the detectors had alternative legal
uses, but the court decided that the “primary and almost exclusive purpose” of the radar
detectors was to “circumvent law enforcement attempts to detect and apprehend those who
violate the law.” Id.
171
See Whistler Corp., 1988 WL 212501, at *1 (rejecting the infringer’s argument that the
invention’s use—circumventing the law—was illegal and therefore, the radar lacked
patentable utility). The infringer, however, did not argue that the invention, the radar, was
illegal. Id.
172
See id. (reasoning a ban on the detectors, not the use of the detectors, would prevent
them from being patentable). The court stated that radar detectors are patentable “unless
and until detectors are banned outright,” instead of indicating that they are unpatentable
unless and until the use of detectors is banned outright. Id. (emphasis added).
173
See id. (concluding that signal radar detectors are patentable, despite being useful
primarily for illegal purposes, until Congress bans detectors or withdraws patents
protection). This conclusion is consistent with the Federal Circuit’s statements in Juicy Whip
indicating the utility doctrine was not in place for the USPTO or courts to serve as arbiters
of what inventions are designed to serve illegal purposes. Juicy Whip, Inc. v. Orange Bang,
185 F.3d 1364, 1368 (Fed. Cir. 1999). The court concluded it is Congress’s job to determine
whether a particular invention should not be patentable. Id. Similarly, the court in Whistler
questioned the possibility of “being required to referee a [public interest] contest among
entities that manufacture and sell products.” Whistler Corp., 1988 WL 212501, at *1.
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subject matter remains legal.174 It also appears the court would not change
its reasoning if the invention could only be used for illegal purposes under
federal law.175 This can also be inferred from the specific words used in
the court’s reasoning, since it noted the primary and almost exclusive use
of the detector was to circumvent the law, but it nonetheless deemed the
device patentable.176
Overall, Fuller is informative of how state laws concerning the use of
an invention would affect a determination of patentable utility. 177
Specifically, under Fuller, state laws prohibiting the use of an invention
should not affect the patentability of an invention. 178 Fuller, however,
sheds no light on whether an invention would be patentable if federal laws
also prohibited the use of the invention. 179 Whistler, however, is
specifically revealing of how a congressional ban on the subject matter of
174
See supra note 171 and accompanying text (explaining that in Whistler, while the accused
infringer argued the invention lacked patentable utility because it was useful for the illegal
purpose of circumventing the law, the court nonetheless ruled the invention was useful
because its subject matter, a radar detector, was not illegal under federal law).
175
See Whistler Corp., 1988 WL 212501, at *1 (concluding that a signal radar detector whose
“primary and almost exclusive purpose” is to circumvent the law has the requisite patentable
utility because the subject matter of the invention, the radar, is not illegal under federal law).
176
See id. (holding that despite the fact the “primary and almost exclusive purpose” of the
radar was to illegally circumvent the law, the radar was patentable unless and until Congress
made a determination to the contrary). This is consistent with Fuller and Juicy Whip. In Fuller,
the court noted that an invention does not lack patentable utility if the invention is used for
vicious purposes, as long as the invention is capable of good uses, even if never used for such
good purposes. See Fuller, 120 F. at 279 (“[E]verything [is] useful within the meaning of the
law, if it is used (or designed and adapted to be used) to accomplish a good result, though
in fact it is oftener used (or is as well or even better adapted to be used) to accomplish a bad
[result].”). In Juicy Whip, the court explained that an invention having the capacity to fool
the public did not lack utility unless Congress declared that particular type of invention
unpatentable. See Juicy Whip, 185 F.3d at 1368 (“Congress is free to declare particular types
of inventions unpatentable for a variety of reasons, including deceptiveness. Until such time
as Congress does so, however, we find no basis in section 101 to hold that inventions can be
ruled unpatentable for lack of utility simply because they have the capacity to fool some
members of the public.”).
177
See supra notes 159, 163 and accompanying text (explaining that Fuller’s holding
suggests state laws concerning the use of an invention do not affect the patentability of the
invention). In Fuller, the court held that a coin detector used with gambling devices did not
lack patentable utility simply because it could be used for illegal purposes under state law.
120 F. at 276.
178
See Fuller, 120 F. at 279 (holding that state laws affecting the use of the invention did not
affect the right granted by a patent to exclude others from using the invention).
179
See id. (discussing the effect state laws—and not federal laws—prohibiting the use of an
invention would have on a patentee’s right to use the invention, but not his right to exclude
others). Fuller does not address whether an invention would be patentable even if federal
laws, whether in contradiction or not with state laws, prohibited the use of the invention. Id.
at 276, 279–80. It also does not address whether state or federal laws banning the subject
matter of an invention would prevent the invention from being patentable. Id.
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an invention would affect the determination of patentable utility. 180
Particularly, under Whistler, an invention would lack patentable utility if
its subject matter were illegal under federal law (“outright” ban by
Congress).181 Whistler also suggests that an invention would not lack
utility if it were useful for purposes banned by Congress, as long as the
subject matter of the invention remains legal.182
As such, Fuller and Whistler suggest the USPTO may have sufficient
legal basis to reject patent applications for lack of legal utility under
limited circumstances.183 Next, these legal bases are applied to marijuanarelated innovations next, to determine whether marijuana-related
inventions lack patentable utility. 184
C. Are Marijuana Plants and Marijuana-Related Inventions Patentable under
Fuller and Whistler?
The USPTO could hypothetically deny marijuana plant patent
applications or marijuana-related patent applications for lack of legal
utility.185 Part III.B indicated that based on Fuller and Whistler, the USPTO
could reject patent applications for lack of legal utility under limited
circumstances.186 This Part of this Note discusses the application of the
legal bases examined in Part III.B to determine whether marijuana-related
inventions are not patentable for lack of legal utility. 187 Even though some
marijuana inventions might not be patentable under Fuller and Whistler
because of marijuana’s status as a controlled substance under federal law,
this Note recommends that illegality should not affect a determination of
patentable utility.188
180
See 1988 WL 212501, at *1 (holding that a signal radar detector used to circumvent the
law was patentable until Congress decided to the contrary).
181
See supra note 170 and accompanying text (concluding that under Whistler, an invention
would not be patentable for lack of utility if a federal law prohibited the subject matter of the
invention).
182
See supra note 173 and accompanying text (explaining that the court’s reasoning focused
on a ban by Congress on the subject matter of the invention and not its use as evidenced by
the court’s choice of words in light of the infringer’s argument).
183
See supra Part III.B (analyzing the moral utility doctrine cases of Fuller and Whistler to
determine what would be the effect of a Congressional ban on the patentable utility of an
invention).
184
See infra Part III.C (applying the legal grounds outlined in Fuller and Whistler to
marijuana-related inventions to determine whether they lack patentable utility).
185
See supra Part III.A (describing the two possible grounds of rejection the USPTO could
assert to deny marijuana-related patent applications).
186
See supra Part III.B (evaluating the effect of a declaration of illegality by Congress on the
evaluation of patentable utility).
187
See infra Part III.C (determining the patentability of marijuana-related inventions under
Fuller and Whistler).
188
See infra Part III.D (suggesting that a court deciding on the patentability of marijuana
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Pursuant to Fuller, state laws concerning the legality of the use of an
invention do not affect the patentability of the invention. 189 Thus, under
Fuller, the fact that using marijuana is legal in some states while illegal in
others would have no bearing on the patentable utility of marijuanarelated inventions.190 Nonetheless, Fuller provides no insight on whether
federal laws regarding the use of an invention would affect the
patentability of the invention.191 Fuller’s holding is arguably limited to the
patentability of inventions where state laws prohibit the use of the
invention but federal law allows it, whereas the issues surrounding the
patentability of marijuana plants and marijuana-related inventions arise
from contradictory state and federal laws.192 Therefore, it is impossible to
discern whether marijuana strains and marijuana-related inventions have
patentable utility under Fuller.
Under Whistler, an invention lacks patentable utility if Congress has
banned the invention’s subject matter. 193 Thus, pursuant to Whistler,
marijuana strains would always lack patentable utility and would not be
protectable because Congress has banned its subject matter. 194 Similarly,
marijuana-related inventions whose subject matter is illegal would also
lack patentable utility.195 Further, under Whistler, an invention has
inventions should hold that such inventions do not lack patentable utility simply because
marijuana is illegal under federal law).
189
See supra notes 159, 163 and accompanying text (analyzing Fuller’s holding to determine
whether precedent suggests what effect, if any, illegality should play in the determination of
patentable utility and concluding the court was not concerned with state laws affecting the
use of the invention).
190
See supra note 160 and accompanying text (noting Fuller indicated state laws only affect
a patentee’s natural right to use his invention but do not affect the rights afforded to him by
his patent to exclude others from using his invention).
191
See supra note 164 and accompanying text (examining Fuller’s holding in context with
the historical background and noting that at the time Fuller was decided, state laws
criminalized gambling, while federal law simply regulated gambling).
192
See supra note 122 and accompanying text (explicating the legality concerns
surrounding the patentability of marijuana strains and marijuana-related inventions).
193
See No. CA3–85–2573–D, 1988 WL 212501, at *1 (N.D. Tex. July 28, 1988) (“Unless and
until detectors are banned outright, or Congress acts to withdraw patent protection for them,
radar detectors patentees are entitled to the protection of the patent laws.”).
194
See 21 U.S.C. § 812 (2012) (criminalizing the possession, manufacture, and distribution
of marijuana). For example, the subject matter of Ben Holmes’s patent application claiming
his Otto II strain is the cannabis strain itself. This strain is illegal under federal law, and thus,
under Whistler, the Otto II would lack patentable utility. See § 812 (classifying marijuana as
a Schedule I substance). Similarly, the subject matter of a utility patent application with
claims directed to the plant would be the plant itself. For example, a patent application
claiming a method for using Holmes’s Otto II strain to treat a disease would lack patentable
utility because using medical marijuana is illegal under federal law. See Marijuana Resource
Center, supra note 36 (“[U]sing marijuana continues to be an offense under Federal law.”).
195
See § 812 (listing marijuana as a prohibited substance under federal law). For example,
a patent application claiming a method for breeding specialty cannabis would not be
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patentable utility irrespective of the invention being useful for illegal
purposes, as long as its subject matter remains legal.196 Accordingly,
marijuana-related inventions whose subject matter is legal would have
patentable utility despite having illegal applications or its use resulting in
illegal activity.197
These results are consistent with the attorneys’ views discussed
earlier—that marijuana-related patent applications that wholly claim
illegal subject matter are not patentable, whereas applications claiming
“around the edges of marijuana” should be patentable. 198 These results
are also supported by the fact that patents have already been granted on
certain applications claiming marijuana-related inventions.199 Therefore,
patentable because the subject matter of the invention, breeding specialty cannabis, is not
legal under federal law. See § 841 (providing it is illegal to manufacture and possess
marijuana); see also Tucker, supra note 121 (indicating a machine specifically designed to
cultivate marijuana would not be patentable). As suggested by Tucker, an attorney could
get away with claiming an invention related to illegal subject matter by describing the
invention in broad terms so that it claims legal subject matter. Tucker, supra note 121. For
example, the method for breeding cannabis could be claimed as simply a method for
breeding specialty plants. See id. (indicating “crafty” patent attorneys should be able to
obtain a marijuana-related patent if they describe and claim non-illegal uses for the
invention). This would not be an option, however, for patents claiming only illegal subject
matter, such as marijuana strains plant patent applications. See id. (“If the invention claimed
by the patent application can only be used for an illegal purpose under federal law, then the
invention would likely be interpreted by the patent office [as] lacking utility, i.e. lacking
usefulness, and therefore be rejected.”) Therefore inventions particularly designed to be
used in association with marijuana—and that can only be used for such purpose—would
lack patentable utility. Id.
196
See 1988 WL 212501, at *1 (holding that whether a device used to circumvent the law is
patentable is a matter “for the legislatures of the states, or for the Congress, to decide[,]” not
the court).
197
See supra note 170 and accompanying text (analyzing Whistler and concluding an
invention would not be patentable if federal law prohibits the subject matter of the
invention). For example, a patent application claiming a method for infusing products with
marijuana would be patentable if the method can be used to infuse products with other legal
substances. Tucker, supra note 121. Notice the subject matter of the invention—the method
for infusing products—is legal under both federal and state law. However, the invention
could serve illegal purposes if used to infuse products with marijuana. See § 841 (possessing
marijuana is illegal under federal law). Other examples of inventions with illegal
applications that would nonetheless be patentable include bongs and vaporizers. See Juneja,
supra note 117 (stating a vaporizer that can be used with legal oils should be patentable). An
example of an invention that would lack patentable utility because both its subject matter
and use are illegal is a method of cultivating a specific marijuana strain that only works for
cultivating that specific marijuana strain. Id.
198
See Davis, supra note 8 (quoting John Dragseth of Fish & Richardson PC: “The office
might be willing to grant patents ‘around the edges’ of marijuana, such as on a software
system for managing marijuana crops, but I think it would have to be legal under federal law
before the patent office is going to allow direct patents on marijuana strains”).
199
See id. (quoting Robert Traver of Sheridan Ross PC, who pointed out the USPTO has
issued patents on smoking paraphernalia that specifically state that the invention is designed
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these results indicate plant patents and utility patents with claims directed
to the plant “face [the] tough[est] road at the USPTO.” 200 However,
illegality should not be considered when determining patentable utility,
and thus, all marijuana strains and marijuana-related inventions should
not lack patentable utility under Whistler because marijuana is illegal
under federal law.201
D. A Solution for the Future
Under Fuller and Whistler, plant patents and utility patents with
claims directed to the plant are most likely not patentable for lack of legal
utility.202 However, the patentability of marijuana strains and marijuanarelated inventions under Fuller and Whistler only reflects the reasoning of
one lower court and an appeals court on an issue that is yet to be directly
addressed by the USPTO, the Federal Circuit, or the Supreme Court.
Specifically, no determination has been made on whether the illegality of
an invention or its application affects a determination of patentable utility
under the “specific and substantial benefit to the public” utility test set
forth in Brenner.203 Therefore, the USPTO could assert marijuana-related
inventions lack patentable utility because the illegal invention is incapable
of providing any benefit to the public. 204 Nevertheless, marijuana-related
inventions should not lack patentable utility simply because the invention
is illegal or has illegal applications. First, Part III.D.1 recommends, if and
when a court hears this issue, it should hold that an invention does not
lack patentable utility if its subject matter is illegal or if the invention can
be used for illegal purposes.205 Next, Part III.D.2 provides commentary on
the holding.
to be used for smoking marijuana). Erich Veitenheimer of Cooley LLP also noted that the
USPTO has issued patents for chemicals isolated from marijuana plants. Id.
200
See id. (exploring why “marijuana patent applications face though road at [the]
USPTO”).
201
See supra Part III.D (recommending courts hold that considering legality when
determining patentable utility would be inconsistent with the goals of the patent system);
1988 WL 212501, at *1 (indicating that a Congress ban on the subject matter of an invention
would prevent the invention from having the requisite patentable utility).
202
See supra Part III.C (applying Fuller and Whistler to marijuana-related inventions to
determine whether the inventions would be patentable despite marijuana’s status as an
illegal substance under federal law).
203
See supra note 85 and accompanying text (stating that no court has determined whether
an invention provides a specific and substantial benefit to the public despite its illegal status).
204
See Davis, supra note 8 (noting that a rejection by the USPTO of a plant patent claiming
a marijuana strain could expressly cite the classification of the drug as illegal or just reject it
for claiming patent-ineligible subject matter).
205
See infra Part III.D.1 (proposing that a court deciding on the patentability of marijuana
inventions should hold that an invention, including marijuana-related inventions, does not
lack patentable utility simply because the invention’s subject matter is illegal or can be used
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Rejections for Lack of Legal Utility Are Inconsistent with the Goals of
the Patent System

Neither courts nor the USPTO have decided whether an invention
lacks patentable utility under the “specific and substantial benefit to the
public” utility test set forth in Brenner if the invention is useful for illegal
purposes.206 This issue, however, will likely reach the courts in the
upcoming years due to the influx of patent applications claiming
marijuana strains and marijuana-related inventions. While dicta in Fuller
and Whistler could provide the legal basis for the USPTO to deny patents
for lack of legal utility, a court hearing the issue should rule that
considering legality when determining patentable utility is inconsistent
with the goals of the patent system and the rights afforded by a patent.
Thus, the USPTO should not deny marijuana-related patent applications
for lack of utility simply based on marijuana’s classification as an illegal
substance under federal law.
2.

Commentary

First, granting a monopoly on an invention whose subject matter is
illegal or that can be used for illegal purposes is not inconsistent with the
rights granted by a patent. A patent grants negative rights, and therefore,
only affords the patentee the right to exclude others from using the
invention.207 A patent, however, does not afford the patentee the exclusive
right to use the invention. The right to use the invention is a natural right
of the inventor and is independent of the legal right to exclude others
afforded by the patent.208 Consequently, a patent claiming subject matter
for illegal purposes). This Note proposes a model judicial holding and reasoning instead of
a statutory amendment for two reasons. First, patent law is rarely amended, and therefore,
a proposed statutory amendment would be inappropriate. See MUELLER, supra note 46, at
33. (explaining the Patent Act of 1952 in amended form governs patent law today and that
only two main revisions have taken place since its enactment: The Patent Act of 1870 and
the Leahy-Smith America Invents Act (“AIA”) in 2011). Second, utility doctrine principles
arise almost exclusively from case law, and thus, the patentability of marijuana is most likely
to happen via court rulings. MUELLER, supra note 46, at 33.
206
See infra Part III.D.2 (highlighting the benefits and issues with a court holding that
inventions do not lack patentable utility merely because the invention’s subject matter is
illegal or because the invention is useful for illegal purposes).
207
See MUELLER, supra note 46, at 15 (stating that patents grant negative rights and
explaining the negative right to exclude granted by patents).
208
See Fuller v. Berger, 120 F. 274, 279 (7th Cir. 1903) (“[S]tate law operates wholly upon
the inventor’s natural right to the use of his property, and not at all upon the franchise which
the patent grants, which consists altogether in the right to exclude.”). Accordingly, in
circumstances where practicing the patent or simply possessing the invention could be
illegal, the patentee has the natural right to practice the invention, but he does not have the
legal right to do so without possibly facing consequences. See id. (explaining that laws
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that is illegal or could be used for illegal purposes would grant the
patentee the right to keep others from engaging in illegal activity, but it
would not grant the patentee the right to engage in illegal activity by
practicing his invention. While the natural right to use the invention is
affected by laws prohibiting the subject matter or use of the invention, the
legal right to exclude others should not be affected.209 For example, if the
USPTO granted patents on marijuana strains, it would not be allowing
patentees to exclusively engage in illegal activity. It would, however,
encourage and allow the patentee to police illegal activity by affording
him the right to exclude others from engaging in such illegal activity as a
result of using the invention and infringing the patent. 210
One could argue, however, that even if granting patents does not
allow patentees to engage in illegal activity, it encourages and enables
others to engage in illegal activity. A patent should disclose an invention
well enough to enable others to practice the invention therein once the
patent expires. Accordingly, patents covering illegal inventions would
allow people to engage in criminal practices unknown to them before the
invention was patented. It seems unlikely, however, that criminals would
resort to the patent system to select their criminal practices. But, if they
did, they would open themselves to an infringement suit. In addition, this
is not a problem limited to patents covering illegal inventions.
Theoretically, every time a patent is published, whether the invention is
illegal or not, competitors are free to copy and practice the inventions
disclosed therein. The only thing keeping them from doing so is the
possibility of an infringement suit. In the case of criminals benefiting from
patents covering illegal inventions, they would not only open themselves
to an infringement lawsuit, but also to prosecution for engaging in
criminal activity. Hence, this argument relates to patent enforcement and
not to the patentability of inventions.

prohibiting the use of the invention only affect the patentees right to use the invention, not
his right to exclude). That, however, is collateral and irrelevant to his right under patent law
to exclude others from using his invention. Id.
209
See id. (“His right to use his property is destroyed, but his right to exclude others stands
unimpaired.”).
210
See 35 U.S.C. § 154 (2012) (providing that patents grant “the right to exclude others from
making, using, offering for sale, or selling the invention . . . .”). Accordingly, it could also be
argued that granting monopolies on illegal inventions would be beneficial to the
government, since enforcement of the patent would result in private enforcement of the law,
helping the police prosecute illegal activity. For example, if Ben Holmes were to obtain a
patent on his Otto II strain, he could sue for infringement whomever asexually reproduces
the progeny of his strain. MUELLER, supra note 46, at 288. If the infringer is located in a state
were marijuana remains illegal, Holmes, if successful in his infringement suit, would be
preventing the infringer from engaging in illegal activity. This could facilitate the DEA’s job.

Produced by The Berkeley Electronic Press, 2017

Valparaiso University Law Review, Vol. 51, No. 3 [2017], Art. 5

690

VALPARAISO UNIVERSITY LAW REVIEW

[Vol. 51

Similarly, if the USPTO were to deny patent applications on the basis
that they involve illegal subject matter or they would lead to illegal
activity, the USPTO would be engaging in policing powers, which
Congress did not afford.211 The utility requirement “is not a directive to
the USPTO or the courts to serve as arbiters” of what is illegal and what is
not, and what inventions people should use and which they should not.212
Other agencies, such as the Federal Drug Administration, the Federal
Trade Commission, and the DEA, are in charge of protecting consumers
from dangerous food or drugs, deceptive products, and the prosecution
for the use of illegal substances. In addition, it would be extremely
burdensome for the USPTO to have to engage in legality determinations,
especially in the case of inventions, like marijuana, which might be legal
in some states while illegal in others. Accordingly, it is up to Congress to
make an explicit determination that illegal subject matter, and inventions
useful for illegal purposes, are not patentable.213 Until Congress does so,
courts should maintain that illegal inventions are patentable provided
they satisfy the other patentability requirements.

211
See Juicy Whip, Inc. v. Orange Bang, 185 F.3d 1364, 1368 (Fed. Cir. 1999) (“Congress
never intended that the patent laws should displace the policing powers of the States,
meaning by that term those powers by which the health good order, peace and general
welfare of the community are promoted.”). It is not the responsibility of the USPTO to
control social behavior by keeping illegal inventions from being patentable. Id. Such is the
responsibility of the states by creating and enforcing laws. Id. Further, the USPTO is not in
charge of protecting users from illegal or harmful inventions. Id. That is the job of other
agencies such as the Federal Trade Commission, the Food and Drug Administration, the
police force, or in the case of marijuana, the DEA. Id.
212
See id. (holding a deceptive device had patentable utility and indicating the utility
requirement “is not a directive to the Patent and Trademark Office, or the courts to serve as
arbiters of deceptive practices”).
213
See Juicy Whip, Inc., 185 F.3d at 1368 (“Congress is free to declare particular types of
inventions unpatentable for a variety of reasons . . . .”); Whistler Corp. v. Autotronics, Inc.,
No. CA3–85–2573–D, 1988 WL 212501, at *1 (N.D. Tex. July 28, 1988) (“Unless and
until . . . Congress acts to withdraw patent protection for them, radar detector patentees are
entitled to the protection of the patent laws.”). In further support of this argument is the fact
that Congress has already expressly withdrawn patent protection from inventions relating
to atomic weapons. See 42 U.S.C. § 2181(a) (2012) (“No patent shall hereafter be granted for
any invention or discovery which is useful solely in the utilization of special nuclear material
or atomic energy in an atomic weapon.”). Such an action by Congress demonstrates that
patent laws should be given a wide scope, unless Congress makes a determination to the
contrary. See Diamond v. Chakrabarty, 447 U.S. 303, 308 (1980) (“Congress contemplated
that the patent laws would be given wide scope . . . .”). In addition, courts and the USPTO
“should not read into the patent laws limitations and conditions which the legislature has
not expressed.” United States v. Dubilier Condenser Corp., 289 U.S. 178, 199 (1933). Thus,
it would be incorrect for the USPTO to consider legality in determining patentable utility
because no such limitation has been provided by the legislature.
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Further, the patent system is in place to encourage dissemination of
information and promote innovation. 214 If illegal inventions are not
patentable, secrecy would be encouraged and secrecy does not promote
progress.215 One might argue that illegal inventions are a detriment to
society. Yet, an invention does not lack beneficial uses simply because it
is illegal. Marijuana is a perfect example since it has been shown that
marijuana has medical benefits—just not benefits recognized by the
federal government.216
Another might argue that Congress could not have intended to
encourage innovation in illegal fields. However, laws and morals change
with time, and laws are constantly subject to review and amendment. So,
while Congress might be concerned with the use of illegal inventions, it
also understands that it is in society’s best interest to encourage disclosure
and innovation in all fields since today marijuana might be illegal, but in
the future it might not.217 Thus, marijuana inventors should not be denied
214
See Brenner v. Manson, 383 U.S. 519, 532–33 (1966) (“[O]ne of the purposes of the patent
system is to encourage dissemination of information concerning discoveries and
inventions.”).
215
See id. (“[I]nability to patent a process to some extent discourages disclosure and leads
to greater secrecy than would otherwise be the case.”); In re Nelson, 280 F.2d 172, 181
(C.C.P.A. 1960) (inhibiting dissemination retards progress). Thus, if illegal inventions are
patentable, the government will be kept on notice of how technology evolves. Such notice,
specifically in areas where it can exercise policing powers, is in the government’s best
interest.
216
See NIDA Research on the Therapeutic Benefits of Cannabis and Cannabinoids, NAT’L INST.
ON DRUG ABUSE (May 2015), http://www.drugabuse.gov/drugs-abuse/marijuana/nidaresearch-therapeutic-benefits-cannabis-cannabinoids
[https://perma.cc/8NNC-W8FP]
(listing the results of studies funded by twenty-eight grants and National Institute on Drug
Abuse (“NIDA”) revealing the therapeutic advantages of marijuana). Like Joseph D.
Summer explained:
Assuming cannabis varieties serve a utilitarian purpose—and medical
evidence suggest they do—providing patents for cannabis varieties
promotes innovation in an industry ripe with opportunity. Cannabis
cultivators will likely develop the best strains in the hopes of achieving
legal legitimacy and protection from the federal government. The
possibilities for invention and innovation are limitless. Preclusion of
cannabis variety patents would likely result in a chilling effect on the
cannabis industry as a whole . . . . [A]ssuming cannabis does have a
medical use, innovation in cannabis varieties may catalyze the
development of unimagined pharmaceutical drugs and spur entirely
new industries.
Joseph D. Summer, Patenting Marijuana Strains: Baking up Patent Protection for Growers in the
Legal Fog of This Budding Industry, 23 J. INTELL. PROP. L. 169, 206 (2015) (internal citations
omitted).
217
See In re Nelson, 280 F.2d at 181 (“Refusal to protect them at this stage would inhibit
their wide dissemination, together with the knowledge of them which a patent disclosure
conveys, which disclosure the potential protection encourages. This would tend to retard
rather than promote progress.”).
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the protections of patent law simply because the inventions cannot be
currently used. Specifically, patent law is not concerned with the use of
an invention, but with the progress fostered by the development of new
technologies. For example, if marijuana inventions were patentable,
inventors would be put on notice of where research and progress in the
field stands, allowing inventors to engage in innovation and research that
produces better and safer technologies.218 Dissemination of information
through patents would offer a better understanding of marijuana and
could potentially lead to discoveries that warrant legalizing marijuana at
the federal level.
However, one could further argue that even if marijuana plants and
marijuana-related inventions were patentable, the patents covering such
inventions would not be enforceable and therefore useless patents.219 This
argument is premised on the fact that courts do not enforce illegal
rights.220 First, assuming the patents would not be initially enforceable,
this argument further highlights the importance of allowing patent
protection for marijuana patents as soon as possible. While the patent
might not be initially enforceable, if marijuana laws were to change within
the next twenty years, which would be the term of these patents if granted,
the patentee would have the ability to sue the infringer once the laws
changed. If the patents were not granted and marijuana later becomes
legal, the patentee will have altogether lost any right to profit from his
invention via the patent system. Second, this argument is only applicable
to those cases in which the patentee is also practicing the invention. Since,

218
For example, if an inventor discovers that a medication with high levels of CBD, but
low levels of THC is useful in treating epilepsy and is granted a patent on such method of
treatment, other inventors will know that such application has been discovered. Thus, they
would be steered towards researching other applications of the ratio or even other ratios to
treat a different illness. But, if the first inventor was not allowed to patent his method, all
inventors could potentially be wasting money in researching the same method of treatment
while their time could be better spent researching and creating a variety of methods of
treatment.
219
See Ciccatelli, supra note 7 (interviewing Douglas J. Sorocco, the director and
shareholder of Dunlap Codding, who “cannot imagine that a federal patent infringement
action on marijuana wouldn’t attract heightened scrutiny to the activities of the alleged
infringer as well as the patent holder.”); Forest, Cannabis IP Remedies: Erie-ly Familiar, Patently
Different, DRUG L. & POL’Y (Apr. 16, 2015), https://druglawandpolicy.wordpress.com/
2015/04/16/cannabis-ip-remedies-erie-ly-familiar-patently-different/ [https://perma.cc/
62TB-VAD6] (discussing whether marijuana-related intellectual property rights would be
enforceable); Milton Springut, High on IP: Marijuana-Related Intellectual Property Law, N.Y.
L.J. (Jan. 12, 2015), http://www.newyorklawjournal.com/id=1202714579594/High-on-IPMarijuanaRelated-Intellectual-Property-Law [https://perma.cc/D547-2FD8] (noting it is
unclear whether a court would enforce marijuana-related patents).
220
See Springut, supra note 219 (explaining that in both contract and tort law, plaintiffs are
unable to pursue legal remedies arising in connection with their own illegal act).
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a patent does not grant the patentee the exclusive right to practice the
patent, it does not necessarily follow that a patentee that seeks to exclude
another from using his invention is himself also using the invention. For
example, if a marijuana plant patent holder seeks to exclude another from
asexually reproducing his strain, it does not follow that the patentee has
been himself reproducing the strain. Thus, patentees seeking to enforce
their rights under the patent, and who have not been practicing the patent,
should have no issues. Lastly, this is an argument of enforceability that
should not bear on the patentability of inventions.
Finally, the Patent Act is silent on morality and illegality, while the
Lanham Act, the statute governing trademark law, contains a morality
clause.221 Congress passed the Lanham Act in 1946, almost ten years
before the Patent Act.222 If Congress intended to limit the patentability of
illegal or immoral subject matter, like it intended to limit the grant of
trademarks on scandalous or immoral marks, it would have included a
morality or legality clause in the Patent Act. Thus, the absence of a
morality or legality clause in the Patent Act further supports the
conclusion that illegal subject matter is patentable.
IV. CONCLUSION
As states legalize medical and recreational marijuana and the industry
continues to grow, entrepreneurs are becoming increasingly interested in
protecting their inventions under patent law. However, patent rights are
established under federal law and marijuana remains illegal federally.
Consequently, attorneys argue it is unlikely that the USPTO will issue
patents protecting marijuana-related inventions. Specifically, courts have
never determined whether illegality affects the patentable utility of an
invention. In the past, courts invalidated patents if they lacked moral
utility under the moral utility doctrine. However, this doctrine is no
longer good law. Nonetheless, some of the cases discussing the moral
utility doctrine suggest that an invention would be unpatentable if
Congress banned the subject matter of the invention. Thus, it appears
marijuana strains and some marijuana-related inventions would not be
patentable.
221
See 15 U.S.C. § 1052(a) (2012) (“No trademark by which the goods of the applicant may
be distinguished from the goods of others shall be refused registration on the principal
register on account of its nature unless it—(a) Consists of or comprises immoral, deceptive,
or scandalous matter . . . .”).
222
See Lanham Act, CORNELL U. L. SCH. LEGAL INFO. INST. (Oct. 30, 2015),
https://www.law.cornell.edu/wex/lanham_act
[https://perma.cc/A4FR-4UZB]
(indicating Congress passed the Lanham Act in 1946 based on the power granted to it by the
Commerce Clause of the Constitution).
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Nonetheless, the USPTO should not deny marijuana-related patent
applications based solely on the fact that marijuana is illegal under federal
law. Accordingly, Ben Holmes’s patent application on his Otto II medicalgrade marijuana strain should be granted provided it satisfies all the
requirements necessary to obtain a plant patent. Specifically, illegality
should not play a role in determining whether an invention is patentable
or not. Considering legality in a determination of patentability would be
inconsistent with the goals of the patent system of promoting disclosure
and innovation. Further, there is no detriment to the public from allowing
the patentability of illegal inventions because patent rights are negative
rights. Last, it is up to Congress to make an explicit determination that
illegal subject matter is not patentable; this is not for the USPTO nor the
courts to decide. Unless, and until, Congress determines illegality should
play a role in determining patentable utility, courts should hold that illegal
inventions cannot be denied for lack of patentable utility. Therefore,
marijuana-related inventions do not lack patentable utility based on
marijuana’s illegal status under federal law.
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